Categories
World News

Covid-19 Information: Reside Updates – The New York Occasions

Here’s what you need to know:

Credit…Steve Helber/Associated Press

Pennsylvania announced statewide restrictions on Thursday that ban indoor dining and close gyms, theaters and casinos for three weeks to stem a “dire” surge in coronavirus cases, and Virginians were asked to stay home from midnight to 5 a.m. until the new year.

The clampdowns came as states across the country reported deaths and cases in numbers never seen before, and hospitals filled beyond capacity. Through Wednesday, there were seven-day records in both cases and deaths.

In Pennsylvania, Gov. Tom Wolf was unsparing Thursday in his characterization of the threat facing his state.

“This virus continues to rage in Pennsylvania,” Mr. Wolf said at a news conference. “Clearly we need to take future mitigation actions and stop the spread of Covid-19. We all hoped it would not come to this. The current state of the surge in Pennsylvania will not allow us to wait.”

And in Virginia, Gov. Ralph Northam announced a new executive order that imposes a nightly curfew, but it was unclear how — and how vigorously — it would be enforced.

The order lists categories of activity that will still be permitted during the curfew, including obtaining food, goods or services; seeking medical or law enforcement help; taking care of people or animals; child care; exercise; traveling to work, school or a house of worship; volunteering for charity; and leaving home to seek safety.

The governor urged residents not to go out without good reason. “We need to take this seriously,” Mr. Northam said. “We need to stay at home.”

But asked how the curfew would be enforced, the governor said it was “about messaging.”

Virginia reported at least 21 new coronavirus deaths and 4,398 new cases on Wednesday. Over the past week, the state has reported an average of 3,521 cases a day, an increase of 41 percent from the average two weeks earlier.

The new order also prohibits all public and private in-person gatherings of more than 10 people who do not live together, with exceptions for work and education, and requires people to wear masks “if they are in an indoor setting shared by others.” The state already requires masks outdoors.

Oklahoma also limited indoor activity, restricting indoor youth sporting events and public gatherings — which includes weddings, funerals and holiday parties held at event centers — to 50 percent capacity for the next 30 days. Places of worship are excluded.

On Wednesday, Pennsylvania reported 8,626 new cases and an additional 247 coronavirus deaths. The daily average over the past week has hovered near 10,000 cases per day, an increase of 51 percent from the average two weeks earlier.

Dr. Jaewon Ryu, the president and chief executive officer of Geisinger Health System, a regional hospital system, said the network was “operating pretty close to 100 percent capacity.”

Mr. Wolf, who announced on Wednesday that he had tested positive for the coronavirus and would be performing his duties remotely, said he was feeling well and that he had tested negative on Thursday. Mr. Wolf’s wife, Francis Wolf, also tested negative.

It was not immediately clear what type of test Mr. Wolf took, or if he had previously felt sick. Some types of coronavirus tests are prone to delivering incorrect results, especially when they are taken by people who are not experiencing symptoms.

Even before Governor Wolf issued his new order, the Pennsylvania House majority leader, Kerry Benninghoff, a Republican, pushed back against what many suspected was coming.

“Governor Wolf, do not cancel Christmas,” Mr. Benninghoff said in a statement. “Do not use your executive order pen to devastate lives and livelihoods. Government mandates will not cure COVID-19 and unilateral shutdowns will not create personal responsibility.”

In Virginia, speaking on the first night of Hanukkah, the governor also called on citizens to remember service members and essential workers during the holiday season.

“I know that Christmas and Hanukkah are truly cherished times,” he said. “The holidays look a bit different this year, and some of the traditions we treasure just aren’t possible.”

But he added, “As we look ahead to a new year, I see reason for hope and optimism that in the coming months, things will be better.”

The Pfizer/BioNTech vaccine being administered at a London hospital this week.Credit…Pool photo by Victoria Jones

Pfizer’s Covid-19 vaccine passed a critical milestone on Thursday when a panel of experts formally recommended that the Food and Drug Administration authorize its use.

The F.D.A.’s vaccine advisory panel, composed of independent scientific experts, infectious disease doctors and statisticians, voted in favor of emergency authorization for people 16 and older.

Although the F.D.A. does not have to follow the advice of its advisory panel, it usually does, and it is likely to do so within days, giving health care workers and nursing home residents first priority to begin receiving the first shots early next week.

The agency may act as soon as Saturday, though officials cautioned that last-minute legal or bureaucratic requirements might delay an announcement.

With that formal blessing, the nation may finally begin to slow the spread of the virus just as infections and deaths surge, reaching a record of more than 3,000 daily deaths on Wednesday.

The initial shipment of 6.4 million doses will leave Pfizer warehouses within 24 hours of being cleared by the F.D.A., according to federal officials. About half of those doses will be sent across the country, and the other half will be reserved for the initial recipients to receive their second dose about three weeks later.

It is the beginning of a complex, monthslong distribution plan coordinated by federal and local health authorities, as well as large hospitals and pharmacy chains.

If successful, the vaccine campaign should help return a grieving and economically depressed country back to some semblance of normal.

“With the high efficacy and good safety profile shown for our vaccine, and the pandemic essentially out of control, vaccine introduction is an urgent need,” Kathrin Jansen, a senior vice president and the head of vaccine research and development at Pfizer, said at the meeting.

The recommendation vote caps a whirlwind year for Pfizer and its German partner BioNTech, which began working on the vaccine 11 months ago, shattering all speed records for vaccine development, which typically takes years.

The Pfizer vaccine has already been given to people in Bahrain and Britain. Canada approved it on Wednesday. A U.S. authorization for it is expected to be followed soon by one for Moderna’s vaccine, which uses similar technology and has also shown promising results in clinical trials.

Dr. Robert Redfield, director of the Centers for Disease Control and Prevention, testifying before Congress in September.Credit…Anna Moneymaker/The New York Times

The editor in chief of a weekly report from the Centers for Disease Control and Prevention has told House Democrats that she was ordered to destroy an email showing that Trump political appointees attempted to interfere with its publication — and that she believes the order came from Dr. Robert R. Redfield, the agency’s director.

The explosive allegation from Dr. Charlotte Kent, the editor of the C.D.C.’s Morbidity and Mortality Weekly Report — the so-called “holiest of the holy” of health reports — is contained in a letter that Representative James E. Clyburn of South Carolina, the No. 3 House Democrat, sent Thursday morning to Dr. Redfield and the health secretary, Alex M. Azar II.

The email in question, dated Aug. 8, was sent by Dr. Paul Alexander, then a senior H.H.S. adviser, Mr. Clyburn’s letter said. In it, Dr. Alexander demanded that the C.D.C. insert new language in a previously published scientific report on coronavirus risks to children, or “pull it down and stop all reports immediately.”

Dr. Kent was on vacation when it arrived; the request to delete the message, she told investigators, was passed on to her by the woman who was filling in for her. She considered the request “very unusual,” she said. And when she tried to comply, she discovered the email had already been deleted — but she told investigators she had “no idea” by whom.

Dr. Redfield has said that the scientific integrity of the M.M.W.R., as the reports are known, has never been compromised — a point he reiterated in a statement on Thursday. He did not deny the order to delete the email, but said he had “instructed C.D.C. staff to ignore” Mr. Alexander’s comments.

“As I testified before Congress, I am fully committed to maintaining the independence of the M.M.W.R., and I stand by that statement.” Dr. Redfield said.

A separate statement from the C.D.C.’s parent agency, the Department of Health and Human Services, called Mr. Clyburn’s letter “irresponsible” and said it mischaracterized Dr. Kent’s testimony. House Republicans then released excerpts from Dr. Kent’s testimony in which she said she was “very committed to maintaining the scientific integrity of the M.M. WR.,” and would never let anything interfere with that.

Mr. Clyburn, who leads a committee that is investigating political interference with the C.D.C., wrote that after Dr. Kent spoke to the panel on Monday, the Trump administration abruptly canceled four more interviews with top C.D.C. scientists and officials, a move the congressman said amounted to obstructing his investigation.

“I am deeply concerned that the Trump administration’s political meddling with the nation’s coronavirus response has put American lives at greater risk,” Mr. Clyburn wrote, “and that administration officials may have taken steps to conceal and destroy evidence of this dangerous conduct.”

He told Mr. Azar and Dr. Redfield that if theydid not produce documents requested by his panel by Dec. 15, he would subpoena the records.

The issue of political interference in the weekly reports burst into the news in September, when current and former senior health officials disclosed that H.H.S. political appointees had repeatedly asked the C.D.C. to revise, delay and even scuttle reports on the coronavirus that they believed were unflattering to President Trump.

One point of contention was the C.D.C.’s guidance on school openings.

Mr. Clyburn’s letter quoted Mr. Alexander’s email as saying: “C.D.C. tried to report as if once kids get together, there will be spread and this will impact school reopening. … Very misleading by C.D.C. and shame on them. Their aim is clear. … This is designed to hurt this Presidnet [sic] for their reasons which I am not interested in.”

Mr. Alexander was dismissed from the department in September.

The committee is now seeking to interview the four other C.D.C. officials whose appearances were canceled: Dr. Anne Schuchat, the principal deputy director; Nina Witkofsky, the acting chief of staff; Trey Moeller, the acting deputy chief of staff; and Kate Galatas, the acting associate director for communications.

Volunteers for coronavirus vaccine trials in Soweto, South Africa.Credit…Jerome Delay/Associated Press

Wealthy nations have a firm upper hand in securing a coronavirus vaccine compared with developing countries, a global coalition of organizations and activists warned on Wednesday.

In about 70 developing countries, only one in 10 residents is expected to receive a Covid-19 vaccine within the next year, according to the People’s Vaccine Alliance, which consists of organizations such as Amnesty International, Frontline AIDS, Global Justice Now and Oxfam.

“The hoarding of vaccines actively undermines global efforts to ensure that everyone, everywhere can be protected from Covid-19,” said Steve Cockburn, Amnesty International’s head of economic and social justice. “Rich countries have clear human rights obligations not only to refrain from actions that could harm access to vaccines elsewhere, but also to cooperate and provide assistance to countries that need it.”

Rich countries representing 14 percent of the global population have bought over 50 percent of promising Covid-19 vaccines, according to data collected by Airfinity, a London-based software company tracking deals between countries and manufacturers. It looked at supply deals that included eight vaccine candidates in Phase 3 clinical trials.

The alliance called on pharmaceutical companies along with researchers to “share the science, technological know-how and intellectual property” of their vaccines. They also asked governments to ensure their Covid-19 vaccines are free to the public and equitably available.

Recently, countries including South Africa and India have pushed for loosened restrictions on intellectual property rights for Covid-19 vaccines, proposing that the World Trade Organization end global enforcement of the rights in the interest of accessibility.

“Governments must also ensure the pharmaceutical industry puts people’s lives before profits,” said Heidi Chow, a senior campaign and policy manager at Global Justice Now.

Developing countries that the alliance focused on currently have access to the vaccine only through Covax, a global initiative to vaccinate much of the world population. (The United States declined to be a part of the effort.)

The United Kingdom started vaccinations this week, after becoming the first Western country to authorize a Covid-19 vaccine. On Wednesday, the United Arab Emirates approved China’s coronavirus vaccine, signaling a win for that country’s vaccine ambitions. Canada approved Pfizer and BioNTech’s coronavirus vaccine, which was also approved in Britain. Both Pfizer and Moderna have submitted their applications for emergency approvals the U.S. Food and Drug Administration and vaccinations in the U.S. could start before next month.

However, the news of vaccination success in wealthy nations hasn’t necessarily equated to access for developing countries: Wealthy nations have purchased enough doses to vaccinate their populations three times over by the end of 2021, the alliance said.

“By buying up the vast majority of the world’s vaccine supply, rich countries are in breach of their human rights obligations,” Mr. Cockburn said. “Instead, by working with others to share knowledge and scale up supply, they could help bring an end to the global Covid-19 crisis.”

Weekly initial jobless claims through the week ending Dec. 5

Pandemic Unemployment

Assistance claims

Jump in claims the week after Thanksgiving

Weekly initial jobless claims through the week ending Dec. 5

Pandemic Unemployment

Assistance claims

Jump in claims the week after Thanksgiving

Applications for jobless benefits resumed their upward march last week as the worsening pandemic continued to take a toll on the economy.

More than 947,000 workers filed new claims for state unemployment benefits last week, the Labor Department said Thursday. That was up nearly 229,000 from the week before, reversing a one-week dip that many economists attributed to the Thanksgiving holiday. Applications have now risen three times in the last four weeks, and are up nearly a quarter-million since the first week of November.

On a seasonally adjusted basis, the week’s figure was 853,000, an increase of 137,000.

Nearly 428,000 applied for Pandemic Unemployment Assistance, a federal program that covers freelancers, self-employed workers and others who don’t qualify for regular state benefits.

Unemployment filings have fallen greatly since last spring, when as many as six million people a week applied for state benefits. But progress had stalled even before the recent increases, and with Covid-19 cases soaring and states reimposing restrictions on consumers and businesses, economists fear that layoffs could surge again.

“It’s very clear the third wave of the pandemic is causing businesses to have to lay people off and consumers to cut back spending,” said Daniel Zhao, senior economist for the career site Glassdoor. “It seems like we’re in for a rough winter economically.”

Jobless claims rose in nearly every state last week. In California, where the state has imposed strict new limits on many businesses, applications jumped by 47,000, more than reversing the state’s Thanksgiving-week decline.

The monthly jobs report released on Friday showed that hiring slowed sharply in early November and that some of the sectors most exposed to the pandemic, like restaurants and retailers, cut jobs for the first time since the spring. More up-to-date data from private sources suggests that the slowdown has continued or deepened since the November survey was conducted.

“Every month, we’re just seeing the pace of the recovery get slower and slower,” said AnnElizabeth Konkel, an economist with the job site Indeed. Now, she said, the question is, “Are we actually going to see it slide backward?”

Many economists say the recovery will continue to slow if the government does not provide more aid to households and businesses. After months of gridlock in Washington, prospects for a new round of federal help have grown in recent days, with congressional leaders from both parties signaling their openness to a compromise and the White House proposing its own $916 billion spending plan on Tuesday. But the two sides remain far apart on key issues.

The stakes are particularly high for jobless workers depending on federal programs that have expanded and extended unemployment benefits during the pandemic. Those programs expire later this month, potentially leaving millions of families with no income during what epidemiologists warn could be some of the pandemic’s worst months.

Richard Hinch was elected speaker of the New Hampshire House of Representatives at an outdoor meeting Dec. 2. He died a week later.Credit…Elise Amendola/Associated Press

The New Hampshire State Legislature was already fiercely divided over the coronavirus when the new Republican speaker of the House of Representatives, Richard Hinch, died suddenly on Wednesday. Then came the news on Thursday that the cause of his death was Covid-19.

Mr. Hinch, who was 71, died just a week after he was sworn in as speaker — and about three weeks after an indoor meeting of his caucus that led to several members contracting the virus, an event that Mr. Hinch had tried to play down in public remarks. It was not clear whether he, too, had caught the virus at the caucus meeting.

The news will undoubtedly heighten tensions among state lawmakers, who have been at odds over the refusal of many Republican lawmakers to wear masks or take other pandemic precautions seriously. Splits have opened not just along partisan lines but also within the Republican ranks.

William M. Marsh, a Republican state representative, said the responsibility for Mr. Hinch’s death lies on the shoulders of a group of Republican members who refused to take precautions like wearing masks and maintaining social distance, and who leaned on others to do the same. “The peer pressure from colleagues is the root cause of what happened to my friend,” Mr. Marsh said of Mr. Hinch.

Democratic lawmakers, who held a majority before the Nov. 3 election, have been in an uproar over the Republican caucus meeting, which was held on Nov. 20 at a ski area. Democrats say they were kept in the dark about the infected lawmakers while Republicans were informed.

The Democratic former speaker, Steve Shurtleff, said he was troubled by Mr. Hinch’s support of Republican lawmakers who refused to wear masks on the House floor, whom Mr. Hinch had called the “patriot section” and the “freedom group.”

“It’s so ironic, looking back,” Mr. Shurtleff said on Thursday. “I know he was just doing his job as a Republican leader, defending his members and his caucus, but it seems so senseless now.”

Mr. Shurtleff said he hoped that the acting speaker would arrange for the House to meet remotely when its next session convenes in January, because he did not expect the mask-resistant Republicans to change their behavior. “I don’t think there will be any remorse,” he said. “There may be remorse at his passing, but not so much at the cause.”

Gov. Chris Sununu, a Republican, said on Wednesday that Mr. Hinch was “a fierce defender” of the state, “a close friend and a respected public servant.” He, too, was critical of lawmakers who refuse to wear masks. “For those who are out there doing just the opposite, just to make some sort of bizarre political point, it’s horribly irresponsible,” he said. “Use your heads, don’t act like a bunch of children.”

The State Senate and House each held their organizational meetings outdoors in 40-degree weather last week. About 130 members of the 400-seat House did not attend in person and were sworn in remotely, according to The Associated Press.

Republican lawmakers in at least two other states where mask wearing and other restrictions have been politically contentious have tested positive in recent days:

  • A South Dakota state senator who attended a dinner with the governor on Monday, and then joined dozens of lawmakers for a budget speech on Tuesday, tested positive on Wednesday. Senator Helene Duhamel of Rapid City posed for a group photo, shoulder to shoulder with Gov. Kristi Noem and more than two dozen other women who attended the dinner. Governor Noem has fiercely resisted imposing a mask mandate or any other restrictions throughout the pandemic, even as the coronavirus raged through the state in the fall, overwhelming its hospitals. The governor’s office insisted that she had not had close contact with Ms. Duhamel, even though they were photographed standing only a few feet apart.

  • The chairman of the appropriations committee in the North Dakota State Senate, Ray Holmberg, confirmed to The Bismarck Tribune on Thursday that he had tested positive, and said he believed he was infected with the virus during the legislature’s organizational session last week. Three employees of the legislature’s nonpartisan research agency have also tested positive, The Associated Press reported.

Ellen DeGeneres announced in a tweet on Thursday that she had tested positive for the coronavirus.Credit…Chris Pizzello/Invision, via Associated Press

“The Ellen DeGeneres Show” has paused filming after its host said on Thursday that she had tested positive for the coronavirus.

“Fortunately, I’m feeling fine right now,’’ Ms. DeGeneres wrote in a statement she posted to Twitter.

Ms. DeGeneres said that anyone who had been in close contact with her had been notified, and that she was following guidelines from the Centers for Disease Control and Prevention.

“I’ll see you all again after the holidays,’’ she wrote. “Please stay healthy and safe.’’

The production company Telepictures, which is a unit of Warner Bros. Television, said in a statement that it had paused filming until January.

The talk show, which films in Burbank, Calif., has been a staple of daytime television since 2003.

After shifting to virtual audiences amid the pandemic, Ms. DeGeneres had resumed filming with a limited live audience in late October. Attendees were required to wear face masks and sit six feet apart.

Ms. DeGeneres had faced accusations of leading a toxic workplace earlier this year, after BuzzFeed News published an article in July in which former staff members said they faced “racism, fear and intimidation” on set. Warner Bros. announced an investigation, three producers left the show, and Ms. DeGeneres apologized on camera and to employees.

The European Medicines Agency, located in Amsterdam, did not disclose who was behind the cyberattack.Credit…Remko De Waal/EPA, via Shutterstock

The European Medicines Agency, the European Union’s top drug regulator, whose approval is necessary for countries in the bloc to begin rolling out the coronavirus vaccine, has begun an investigation after it was hit by a cyberattack, it said on Wednesday.

The agency, which is reviewing vaccine candidates, did not provide details about the target or the date of the attack. But shortly after the announcement, Pfizer and BioNTech said in their own statement that some documents related to the regulatory submission of their vaccine and which were hosted on a server of the European agency, had been “unlawfully accessed.”

Pfizer and BioNTech said their systems had not been breached, and that no study participants appeared to have been identified as a result of the cyberattack.

The breach comes at a time of heightened threats faced by pharmaceutical companies, health care institutions and agencies involved in the production, approval and distribution of the vaccine.

Last week, IBM said it had detected a series of cyberattacks in September against companies involved in the distribution of coronavirus vaccines across the world and against a branch of the European Commission, the E.U.’s executive arm.

The European Medicines Agency is set to announce a decision on the Pfizer/BioNTech vaccine by Dec. 29. Although each country in the bloc will be in charge of its own rollout, the agency’s approval will pave the way for the largest vaccination campaign in the West, dwarfing the rollout that started this week in Britain and most likely posing more considerable logistical and security challenges.

Canada approved the Pfizer/BioNTech vaccine on Wednesday, becoming the second Western country to do so. Russia began the rollout of its own Sputnik 5 vaccine on Saturday.

The European Medicines Agency didn’t disclose who was behind the cyberattack, saying that it “cannot provide additional details whilst the investigation is ongoing.” Pfizer and BioNTech said in their statement that they were awaiting further information from the agency.

Cybersecurity experts have said that only state actors could carry out such operations. Microsoft revealed last month that hacker groups backed by Russia and North Korea had targeted several vaccine makers in the United States, Canada and France, among other countries.

“The intentions behind those attacks are to parasite Western efforts on the vaccine,” said Julien Nocetti, a researcher at the French Institute of International Relations who studies cybersecurity with a focus on Russian activities.

By breaking into the system of key actors involved in the vaccine or by disrupting distribution efforts, attackers could exact considerable damage, said Claire Zaboeva, a senior cyberthreat analyst at IBM’s Security X-Force.

Ms. Zaboeva said about the production and delivery of the vaccine: “If you manage to get the key to the whole kingdom, you have 500 options on the menu: collecting key timetables, which nations will get the vaccine, how it will get there, what companies will be associated with the delivery, or how it will be handled.”

Healthcare workers and the Connecticut National Guard administering coronavirus tests in Stamford, Conn., on Wednesday.Credit…Dave Sanders for The New York Times

Months into the pandemic, many people still are frustrated and confused about virus testing.

Long lines at testing sites, delays in getting results and even surprise testing bills have discouraged some people from getting tested.

And many people don’t understand what a test can and can’t tell you about your risk, and wrongly think a test result that comes back negative guarantees they can’t spread the virus to others.

We asked some of the nation’s leading experts on testing to help answer common questions about how to get tested, what to expect and what the different tests and results really mean.

Among them:

  • When should be people be tested?

  • What are the tests like?

  • What type of test should people get?

  • And how do you interpret the results?

Airlines are just one piece of a massive global machine cranking up to tackle one of the biggest logistical challenges in recent memory.Credit…Kriston Jae Bethel for The New York Times

Months before anyone knew which of the coronavirus vaccine candidates would pull ahead or when they’d be available, airlines were trying to figure out how to transport doses around the world.

Over the summer, American Airlines, Delta Air Lines and United Airlines spoke with government officials, pharmaceutical companies and experts to understand where vaccines might be produced, how they would be shipped and how best to position people and planes to get them moving. More recently, they have flown batches of vaccines for use in trials and research or to prepare for wider distribution.

The industry will play a vital role in moving billions of doses in the months ahead, putting underused planes and crews to work while circulating the very medicine that airlines hope will get people to book tickets again.

“When a request comes in, it’s going to be urgent and we have to act immediately,” said Manu Jacobs, who oversees shipments of pharmaceuticals and other specialty products for United.

One of the biggest challenges for airlines has been ensuring that vaccines are transported at frigid temperatures. Pfizer’s must be stored at an incredibly low minus-94 degrees Fahrenheit. Moderna’s can be kept at a more easily managed minus-4 degrees.

For its vaccine, Pfizer designed special cooler containers that can be stuffed with dry ice, which is solid carbon dioxide. But aviation authorities limit how much dry ice can be carried on planes because it turns to gas, making the air potentially toxic for pilots and crews.

After running tests that showed it was safe, United last month asked the Federal Aviation Administration to raise the limit so it could fly the Pfizer vaccine from Brussels International Airport to Chicago O’Hare International Airport, according to an F.A.A. letter. The agency allowed the airline to carry up to 15,000 pounds of dry ice aboard a Boeing 777-224 plane, compared to the previous limit of 3,000 pounds, according to the letter. A single 777 can carry up to one million doses, the airline said.

In normal times, about half of all air cargo is transported by airlines, often beneath the feet of passengers. The steep decline in flights this spring removed much of that capacity, but the urgent need for masks, gloves and ventilators created a big opportunity for cash-starved carriers, allowing them to recapture at least some of that lost business.

Quarantine orders for the passenger’s close contacts aboard the ship were rescinded after he tested negative.Credit…Edgar Su/Reuters

An 83-year-old passenger who initially tested positive for the coronavirus on a “cruise to nowhere” from Singapore this week, forcing thousands of passengers and crew members to return to port a day early, did not have the virus after all, officials said on Thursday.

The passenger, who had diarrhea aboard the ship Quantum of the Seas and had taken a mandatory Covid-19 test, has since tested negative several times, Singapore’s Ministry of Health said in a statement.

“The sample taken from the individual this morning came back negative for the virus,” officials said on Thursday. It was the third negative test after two on Wednesday also came back negative.

Quarantine orders for the man’s close contacts and other passengers aboard the ship were then rescinded, the ministry said.

Singapore’s Tourism Board said that contact tracing began immediately after the man’s positive test and that all leisure activities on board were canceled. The ship’s captain had also ordered guests to remain in their cabins during the investigation.

Quantum of the Seas, which is owned by Royal Caribbean, returned to the Marina Bay Cruise Center in Singapore at 8 a.m. Wednesday. All remaining passengers and crew members were required to undergo mandatory testing upon disembarking, the tourism board said.

The board also asked that passengers monitor their health for 14 days and to undergo a swab test at a designated government center at the end of the monitoring period.

When the cruise left the city-state on Monday, all 1,680 passengers and 1,148 crew members had tested negative for Covid-19, according to the tourism board.

The incident underscores the uncertainties the global tourism industry, battered by the pandemic, faces as it struggles to restart. The cruise ship is one of two to operate out of Singapore this month while putting in place a long list of safety precautions to reassure passengers.

A New York Times reporter recently took a trip on the other one, the World Dream.

In February, the coronavirus infected more than 200 people board the Diamond Princess cruise ship, trapping its 3,600 passengers and crew. Governments later banned cruises, crews were sent home, and passengers canceled their bookings. But countries like Singapore, Japan and several in Europe have since allowed cruises to restart under the watchful eye of officials.

Dr. Vivek H. Murthy advised the N.C.A.A. Board of Governors in the early days of the coronavirus pandemic.Credit…Hilary Swift for The New York Times

President-elect Joseph R. Biden Jr.’s choice for surgeon general, Dr. Vivek H. Murthy, had a central role in the National Collegiate Athletic Association’s decision in March to cancel this year’s national basketball tournaments — one of the earliest and most culturally significant signs that the virus would upend ordinary life in America.

The work of Dr. Murthy, a member of the association’s powerful Board of Governors who was surgeon general during part of the Obama administration, offers a view into how he approached the pandemic’s initial threat in the United States, and how he might help shape the federal government’s response under Mr. Biden.

A newcomer to the insular world of college athletics, Dr. Murthy proved a cautious, deliberate expert who was wary of making drastic decisions prematurely, interviews with more than a dozen people who participated in the N.C.A.A.’s meetings suggest. But they said that as the tournaments approached and more data and scientific research emerged, Dr. Murthy was a forceful and effective champion of measures that had been unthinkable to most of society only days or weeks earlier.

Indeed, it was Dr. Murthy who urgently told board members that they risked fueling a deadly crisis if they allowed the tournaments to proceed as scheduled.

“He was instrumental in convincing the board that the time to act was now,” said Kenneth I. Chenault, a former chairman of American Express who sits on the N.C.A.A. board.

But board members like Mr. Chenault said that it was plain that Dr. Murthy understood the cultural and financial repercussions of a decision like canceling the basketball tournaments, which generate hundreds of millions of dollars.

GLOBAL ROUNDUP

A market in Seoul, South Korea, on Tuesday. Health officials warned that ​the number of coronavirus cases could rise to record highs in coming days.Credit…Kim Hong-Ji/Reuters

For most of the year, South Korea has kept its coronavirus numbers so low it was the envy of the world. Now, the country is grappling with the most elusive wave of infections it has seen, just as other nations prepare to roll out vaccinations.

South Korea’s daily number of new cases was once as low as two per day. That number soared to​ 682 on Thursday, with health officials warning it could reach record highs in coming days. On Wednesday​, 686 new cases were reported, the highest daily count since Feb. 29.

“We must exert all we can, considering this is our last hurdle to clear ​in our efforts to curb the coronavirus before vaccines and treatments come online,” President Moon Jae-in said this week. He has instructed his government to mobilize ​​soldiers​, police officers and civil servants ​to help epidemiologists’ contact-tracing efforts.

The country’s struggle to contain the recent surge is a race against time. Mr. Moon’s government announced this week that it had secured enough doses of coronavirus vaccines from companies like AstraZeneca and Pfizer to inoculate roughly 86 percent of the population, but that the first batch would not arrive until March.

South Korea has been hit by four waves of infections since its first case was reported in January. But the latest is by far the ​hardest to control, health officials said.

Previous waves included mass clusters that health officials were able to target and trace. The current wave spread through numerous small clusters that erupted in nursing homes, hospitals, saunas, bars, restaurants, music halls and factories, most of them in the Seoul metropolitan area, but also in towns farther away.

Daily cases continue to rise despite tightened social-distancing ​guidelines and other measures. Na Seong-woong, a deputy commissioner of the Korea Disease Control and Prevention Agency, warned that the daily caseload could surpass 900 next week.

“We are facing our biggest ever coronavirus crisis because the current wave is neither temporary nor regional, but steady and nationwide,” he said. “We don’t have one central cluster that we can shut down with a focused testing and isolating campaign, but it’s popping up here and there and everywhere through our daily lives.”

In other developments across the world:

  • Spain was hit far worse during the first wave of the coronavirus than official data showed at the time, according to new statistics published by Spain’s national statistics institute on Thursday. The institute said 45,684 people had died of Covid-19 between March and May, compared to the 27,127 dead that Spain’s health ministry had reported by May 31. The health ministry counts only deaths officially attributed to Covid-19, while the statistics institute counted those who died with the disease as the most likely cause.

  • Hospitals in Tokyo were strained as Japan’s capital city reported 602 new cases on Thursday, its first time topping 600 cases in a day, officials said. Government officials have recommended that residents avoid outings.

  • Pope Francis will hold midnight Mass in Rome two hours earlier on Christmas Eve than he has in previous years, beginning at 7:30 p.m. to comply with Italy’s 10 p.m. curfew. The pope will also give his annual Christmas Day blessing at noon from inside St. Peter’s Basilica instead of from the loggia, where thousands would usually gather.

  • Secondary school students in the seven worst-hit areas of London will be tested for the virus, Britain’s health secretary, Matt Hancock, said at a news conference on Thursday evening. Mr. Hancock said that group of students, which he described as being ages 11 to 18, is by far accounting for the fastest rise in cases, and that the virus rate among adults in London is “broadly flat.” He urged secondary school students to get tested regardless of whether they had symptoms and said more details on the plan would follow Friday. Mr. Hancock said with the vaccine now being administered in Britain, there is hope on the horizon. “So don’t blow it now.”

  • In New York City, Mayor Bill de Blasio outlined a plan on Thursday, without providing much specific detail, to help students recover from the educational disruption caused by the pandemic. “Clearly, there will be a Covid achievement gap, and we have to close that,” he said. The mayor noted several areas he would focus on before the start of the next school year in September: finding a baseline for the academic ground lost; developing digital content and a learning hub; expanding professional development; enlisting parents to help more in education; and helping students deal with mental health issues and trauma related to the pandemic.

The reopening of theaters, museums and cinemas in France will be delayed for another three weeks.Credit…Abdulmonam Eassa/Agence France-Presse — Getty Images

The French government on Thursday said that it will delay relaxing some Covid-19 lockdown restrictions because rates of new cases were not falling as fast as expected.

The reopening of theaters, museums and cinemas, which was planned for Dec. 15, will be pushed back another three weeks, and a curfew that will replace the current lockdown will run earlier than planned.

The authorities had announced that a reprieve from the restrictions would be implemented on the condition that France reached a target of 5,000 new cases per day and fewer than 3,000 Covid-19 patients in intensive care.

Although the target of 3,000 patients in intensive care is within sight, France on Wednesday reported about 15,000 new cases, dampening hopes that daily new cases could fall to 5,000 by next Tuesday.

“We are not yet at the end of this second wave and we will not reach the objectives we had set,” Prime Minister Jean Castex said at a news conference on Thursday.

“The battle is far from won,” he said, adding that although the health situation improved for the past few weeks, it has plateaued in recent days.

The health minister Olivier Véran said that “we know that from plateau to peak sometimes things can go very fast.”

France will stick to a previously announced plan to end the lockdown on Dec. 15 and replace it with a nightly curfew. But in a departure from the plan, the curfew will start one hour earlier, at 8 p.m., and will not be waived for New Year’s Eve.

An exception will be made for Dec. 24, Christmas Eve, when people will be allowed to move freely during the night.

“The risk is that if we don’t change anything, the second wave will start again in the next few weeks,” Mr. Véran said.

On Thursday, the French Senate released a scathing report of a parliamentary commission that dissected the government’s failures in its handling of the coronavirus crisis and denounced “late and uncoordinated decisions” that delayed the government’s response to the pandemic.

The report specifically pointed to the failure of the government’s management of critical stocks of face masks. “The shortage of masks will remain the unfortunate symbol of the unpreparedness of the country and the lack of anticipation of the health authorities in the face of the crisis,” the report said.

It pointed out that Jérome Salomon, a top official at the health ministry, chose not to replenish stocks of masks in 2018, despite being warned about risks of shortages, and lobbied to retrospectively amend a scientific report in order to justify this decision. In a statement sent on Thursday night, Mr. Salomon denied that any pressure was exerted on the authors of the report.

“The mask fiasco was deliberately concealed by the government during the crisis,” the report said, adding that “a communication crisis has undermined the credibility of public and scientific discourse, the effects of which will be lasting.”

The parliamentary commission added that France’s strategy to test, trace and isolate in order to prevent a second wave of the virus proved unsuccessful, because of backlogs of test results, a limited contact tracing operation and an almost nonexistent isolation strategy.

Mr. Castex did not comment on the report, but acknowledged that a sense of fatigue surrounding the pandemic was growing in the country.

“I know your weariness, your doubts, your suffering,” Mr. Castex said. “I share them.”

Staff aides to Senate Majority Leader Mitch McConnell warned that most Republicans are unlikely to support the bipartisan plan.Credit…Anna Moneymaker for The New York Times

Staff aides to Senator Mitch McConnell of Kentucky, the majority leader, have informed other congressional leaders that it is unlikely that the majority of Republicans could support compromise provisions addressing liability protections and state and local government funding in a $908 billion stimulus deal being hammered out by a bipartisan group of moderates.

Their warning reflected the deep resistance among several Republicans for another large round of federal relief. For months their reluctance has helped to stymie agreement on an economic recovery plan to help struggling businesses and individuals amid the pandemic. Mr. McConnell and Republicans have been particularly resistant to providing billions of dollars to cash-strapped state and local governments, a top Democratic priority that would receive $160 billion under the moderates’ emerging outline.

That package is likely to contain some form of limited liability protection to businesses, schools and hospitals, which most Democrats have dismissed as a nonstarter, but the shield could be temporary and not as sweeping as the one that Mr. McConnell has demanded, which prompted the private skepticism.

The potential Republican antipathy for the compromise that was conveyed by Mr. McConnell’s staff was first reported by Politico, and was relayed on condition of anonymity by a senior Democrat familiar with the conversation. Mr. McConnell’s office declined to comment.

“My view is that the best thing that could happen is the pieces of this that everybody agrees on, take that out — take the funding for state local governments out — and pass the rest of it,” Senator John Thune of South Dakota, the No. 2 Republican, told reporters, offering a suggestion Democrats have panned.”

The bipartisan group is still struggling to finalize its agreement, let alone produce legislation that could be voted on in the coming days.

With just a handful of days before the end of the 116th Congress and a number of critical programs established in previous coronavirus legislation set to expire, lawmakers agree that both chambers should not leave Washington until they reach consensus on both an omnibus government spending package and a pandemic aid deal.

The Senate is expected to approve a one-week stopgap bill before funding lapses on Friday, intended to buy additional time for negotiators on both issues. But the timing of the vote was unclear as of Thursday afternoon.

Top Democrats have signaled support for the bipartisan discussions, led by a handful of moderate lawmakers in both chambers, as a possible avenue for a final agreement. But in doing so, Democrats also rejected a proposal from Mr. McConnell to remove the provisions related to state and local government and liability protections and focus on approving funding for schools, education and small businesses.

Steven Mnuchin, the Treasury Secretary, presented Ms. Pelosi on Tuesday with a $916 billion alternative, but she and other Democrats rejected it given that it failed to revive lapsed federal supplemental jobless payments. Instead, it would include a round of $600 stimulus checks, half the amount initially approved earlier this year.

Categories
Business

Unemployment Claims Rise as Financial Disaster Grinds On: Reside Updates

Here’s what you need to know:

Credit…Anna Moneymaker for The New York Times

The Treasury secretary, Steven Mnuchin, was rebuked on Thursday at a congressional oversight hearing over his management of the economic relief effort, facing criticism from lawmakers over his decision to pull the plug on five of the Federal Reserve’s emergency lending programs.

Scrutiny of Mr. Mnuchin’s handling of the programs comes as he is negotiating with Congress over another $900 billion economic relief bill that lawmakers hope to pass before the end of the year.

The criticism over Mr. Mnuchin’s decision to end the Fed programs adds to the controversy surrounding one of his final acts as Treasury secretary. Mr. Mnuchin insisted again on Thursday that he was following the intent of the law in ending the lending programs at year-end and in clawing back billions from the Fed. That position is at odds with what many legal experts and Democrats in Congress say was actually required under the law.

“This was a political decision — one intended to hamstring the incoming administration even as Covid deaths are spiking and the economic recovery is slowing,” Bharat Ramamurti, an appointed member of the Congressional Oversight Commission, said at Thursday’s hearing. “Let me put it this way: Does anyone think the Treasury would have ended these programs if Donald Trump were re-elected?”

Mr. Ramamurti, a Democrat, noted that Mr. Mnuchin’s decision was only made public after the election and that Treasury had earlier indicated that the programs could continue depending on market conditions.

On Nov. 19, Mr. Mnuchin declared that the he believed all along that the programs could not continue past year-end and asked the Federal Reserve to give back the unused investments.

Mr. Mnuchin was also grilled over Treasury’s decision to extend a loan to a trucking company that was struggling before the coronavirus.

Republicans on the commission, Senator Patrick J. Toomey of Pennsylvania and Representative French Hill of Arkansas, both raised questions about why the company, YRC Worldwide, was worthy of loan that was justified on the grounds that the company was critical to national security.

“It’s been hanging on by a thread since the global financial crisis,” Mr. Hill said.

Mr. Toomey said that YRC, which had been contracted by the Defense Department to provide meal kits, protective equipment and other supplies to military bases, appeared to be nearly insolvent and asked whether giving it money was a prudent use of taxpayer funds.

Mr. Mnuchin, a former banker, agreed that he would not have underwritten the loan if he was still in private industry but said the law gave Treasury the ability to help prevent financial problems and job losses at companies deemed critical to national security.

There was a tremendous risk to the Deparment of Defense and a tremendous risk to the number of jobs,” Mr. Mnuchin said.

Lawmakers also pressed Mr. Mnuchin about one of YRC’s financial backers, Apollo Global Management, a private equity firm that also has ties to the White House.

Mr. Ramamurti asked Mr. Mnuchin if Jared Kushner, President Trump’s son-in-law and senior adviser, had encouraged him to approve the loan. In 2017, Apollo lent $184 million to Mr. Kushner’s family real estate firm, Kushner Companies, to refinance the mortgage on a Chicago skyscraper.

Mr. Mnuchin said that Mr. Kushner had no input and defended the loan, claiming that it staved off substantial job losses.

“I do think it would have been bankrupt and the company would have fired lots of people,” Mr. Mnuchin said.

Pandemic Unemployment

Assistance claims

Pandemic Unemployment

Assistance claims

Applications for jobless benefits resumed their upward march last week as the worsening pandemic continued to take a toll on the economy.

More than 947,000 workers filed new claims for state unemployment benefits last week, the Labor Department said Thursday. That was up nearly 229,000 from the week before, reversing a one-week dip that many economists attributed to the Thanksgiving holiday. Applications have now risen three times in the last four weeks, and are up nearly a quarter-million since the first week of November.

On a seasonally adjusted basis, the week’s figure was 853,000, an increase of 137,000.

Nearly 428,000 applied for Pandemic Unemployment Assistance, a federal program that covers freelancers, self-employed workers and others who don’t qualify for regular state benefits.

Unemployment filings have fallen greatly since last spring, when as many as six million people a week applied for state benefits. But progress had stalled even before the recent increases, and with Covid-19 cases soaring and states reimposing restrictions on consumers and businesses, economists fear that layoffs could surge again.

“It’s very clear the third wave of the pandemic is causing businesses to have to lay people off and consumers to cut back spending,” said Daniel Zhao, senior economist for the career site Glassdoor. “It seems like we’re in for a rough winter economically.”

Jobless claims rose in nearly every state last week. In California, where the state has imposed strict new limits on many businesses, applications jumped by 47,000, more than reversing the state’s Thanksgiving-week decline.

The monthly jobs report released on Friday showed that hiring slowed sharply in early November and that some of the sectors most exposed to the pandemic, like restaurants and retailers, cut jobs for the first time since the spring. More up-to-date data from private sources suggests that the slowdown has continued or deepened since the November survey was conducted.

“Every month, we’re just seeing the pace of the recovery get slower and slower,” said AnnElizabeth Konkel, an economist with the job site Indeed. Now, she said, the question is, “Are we actually going to see it slide backward?”

Many economists say the recovery will continue to slow if the government does not provide more aid to households and businesses. After months of gridlock in Washington, prospects for a new round of federal help have grown in recent days, with congressional leaders from both parties signaling their openness to a compromise and the White House proposing its own $916 billion spending plan on Tuesday. But the two sides remain far apart on key issues.

The stakes are particularly high for jobless workers depending on federal programs that have expanded and extended unemployment benefits during the pandemic. Those programs expire later this month, potentially leaving millions of families with no income during what epidemiologists warn could be some of the pandemic’s worst months.

Dara Khosrowshahi, Uber’s chief executive, said that drivers had served as a “lifeline” during the pandemic by delivering food and transporting health care workers.Credit…Jeenah Moon for The New York Times

Uber drivers and food delivery couriers should get priority access to the coronavirus vaccine, Dara Khosrowshahi, Uber’s chief executive, wrote in a letter to the governors of all 50 states.

Arguing that drivers had served as a “lifeline” during the pandemic by delivering food and transporting health care workers, Mr. Khosrowshahi said that they had earned a spot near the front of the vaccination line alongside other kinds of frontline workers.

“As you finalize your state-level allocation and distribution plans, I encourage you to recognize the essential nature of their work” Mr. Khosrowshahi wrote to the governors. “I want to ensure these individuals can receive immunizations quickly, easily and for free.”

He also offered to use Uber’s app to promote the vaccine and said Uber could be used to help people get to vaccination appointments.

The Centers for Disease Control and Prevention has recommended that health care workers who are at risk of contracting the virus and residents of long-term care facilities should be the first people to receive the vaccine.

Essential workers should be next, the C.D.C. suggested. But individual states have varied definitions of which workers meet the criteria. Uber drivers should be considered in that phase, Mr. Khosrowshahi said.

Volunteers prepare food for families in need in Newton Centre, Mass. Two federal unemployment programs are set to expire, potentially leaving millions vulnerable to eviction and hunger.Credit…Cody O’Loughlin for The New York Times

Millions of Americans will lose their only income in a few weeks if Congress doesn’t act soon to extend unemployment benefits.

Congress created two programs in the spring to expand the unemployment safety net: Pandemic Emergency Unemployment Compensation, which offers 13 weeks of payments to people whose regular state benefits have run out, and Pandemic Unemployment Assistance, which is intended for people left out of the regular unemployment insurance system. But the week ending Dec. 26 is the last for which people can claim benefits under the programs.

Figuring out how many people stand to lose benefits is surprisingly difficult. Data from the Labor Department on Thursday showed that 4.5 million people were enrolled in the program to extend state benefits as of the third week of November. That was down slightly from a week earlier but had been rising quickly as people exhaust their regular benefits, which last six months in most states. If the program ends, some people will qualify for a separate federal extended benefits program, but that extension isn’t available in all states.

Pandemic Unemployment Assistance is even more complicated. The report on Thursday showed that 8.6 million people were enrolled, but that figure is almost certainly an overestimate. A recent report from the Government Accountability Office found that the program had been plagued by fraud and double counting, rendering the data unreliable.

By any accounting, however, millions stand to lose their income if the programs end. Many have already drawn down savings, leaving them with little financial cushion and putting them at risk of eviction or foreclosure.

“They’re going to be very quickly forced to make a lot of bad financial decisions to put food on the table,” said Andrew Stettner, a senior fellow at the Century Foundation, a progressive group. “It can be something you can’t recover from or that takes years to recover from.”

Outside the European Central Bank’s former headquarters, in Frankfurt. Credit…Yann Schreiber/Agence France-Presse — Getty Images

The European Central Bank administered another dose of stimulus to the eurozone economy on Thursday, as policymakers signaled that they expected the impact of the pandemic to linger into 2022 even as the rollout of vaccines begins.

The bank’s Governing Council, which met on Wednesday and Thursday, extended and enlarged programs intended to keep borrowing costs low for eurozone businesses and consumer.

The bank said it would increase pandemic-related bond buying — essentially a money-printing program — by 500 million euros, to a total of €1.85 trillion euros, or $2.2 trillion. The bank said it expected to continue the purchases at least until March 2022, nine months longer than planned.

The central bank also extended by a year, to June 2022, an initiative that allows commercial banks to borrow money at negative interest rates, provided the banks pass the credit on to their customers.

The decisions indicate that the European Central Bank’s Governing Council believes economic recovery is still months away, and extraordinary measures are needed to blunt the damage caused by the pandemic.

A second wave of coronavirus infections provoked a renewed economic downturn in the last quarter of this year, prompting the bank to take action, Christine Lagarde, the president of the European Central Bank, told reporters during a news conference.

The most recent analysis by central bank economists suggests “a more pronounced near-term impact of the pandemic on the economy and a more protracted weakness in inflation than previously envisaged,” Ms. Lagarde said.

The new burst of stimulus was not a surprise after Ms. Lagarde telegraphed policymakers’ intentions at a news conference in October, and repeated the message several times afterward. The only unknowns were what precise form the stimulus would take, and how big it would be.

The measures announced Thursday were in addition to 1.35 trillion newly created euros that the central bank had allocated to buy government and corporate bonds. The purchases are a way of pushing down market interest rates to keep borrowing costs low.

Since April, the central bank has also been lending to commercial banks at interest rates as low as minus 1 percent, in effect paying lenders to take the money as a way of pumping credit into the economy. The commercial banks must lend the money to their customers and meet other conditions to qualify.

United Airlines agreed to invest in a venture plans to build large plants where carbon will be captured from the air and stored underground.Credit…Jeff Chiu/Associated Press

United Airlines said on Thursday that it planned to reduce its greenhouse gas emissions to zero by 2050, in part by investing in capturing and storing carbon.

The airline said it had agreed to invest in 1PointFive, a joint venture between a subsidiary of Occidental Petroleum and Rusheen Capital Management, a private equity firm. That venture plans to build large plants in the United States where carbon will be captured from the air and permanently stored deep underground. Each plant will be designed to remove a million tons of carbon dioxide a year, or the equivalent of the carbon removed by about 40 million trees, according to the airline.

United is among a growing list of companies to promise to effectively eliminate their contribution to climate change. Airlines face a particularly difficult challenge because the technology to produce a zero-emission jet that can economically ferry hundreds of people over long distances does not yet exist and may not for decades.

Some experts and corporate leaders, including United’s chief executive, Scott Kirby, said the world would not be able to meet its climate goals without capturing carbon dioxide in the air and storing it in perpetuity. The approach is technically feasible, but it is expensive and has yet to be deployed on a large scale.

“Everyone that really wants to get the globe down to zero is going to have to come to grips with direct capture and sequestration because that is going to be the only way to get there by 2050,” Mr. Kirby told reporters on a call on Wednesday.

To meet its goal, United also plans to invest in the development and use of “sustainable fuel” and undertake other measures. American Airlines recently announced a similar pledge to achieve net zero carbon emissions by 2050, and Delta Air Lines said this year it would invest $1 billion to become the world’s “first” carbon neutral airline.

  • Stocks drifted between gains and losses on Thursday, as new data showed that unemployment claims jumped sharply in the United States last week, and the European Central Bank’s plans to expand stimulus measures fell short of what some traders were expecting.

  • The S&P 500 fell half a percent in early trading before recouping those losses. The Stoxx Europe 600 slipped about 0.8 percent, while the FTSE 100 index in Britain was flat after giving up its early gains.

  • The Labor Department said on Thursday that more than 947,000 workers filed new claims for state unemployment benefits last week, up nearly 229,000 from the week before. Applications have now risen three times in the last four weeks.

  • The report highlights the importance of a new economic stimulus plan to shore up households and businesses as the pandemic grinds on. Prospects for a new round of federal help have grown in recent days, with the White House proposing its own $916 billion spending plan on Tuesday. But lawmakers remain far apart on key issues.

  • The E.C.B., which has bought more than 600 billion euros’ worth of European bonds as part of an effort to keep government borrowing costs low, said on Thursday that it would increase its bond-buying plan by 500 billion euros and keep purchasing the debt until at least March 2022.

  • The pound fell against all other major currencies, losing 0.9 percent against the euro and 0.6 percent against the dollar, after Prime Minister Boris Johnson of Britain returned from Brussels without a breakthrough on Brexit trade talks with the European Union. The two sides have set a new deadline of Sunday to secure a deal.

  • On Wednesday, Britain signed trade agreements with Singapore and Vietnam. Britain has rushed to sign dozens of free-trade agreements with countries because on Jan. 1 it will be independent of the European Union customs union. The agreements essentially replicate the terms of the E.U. pacts with those countries.

Merck’s chief executive, Kenneth C. Frazier, will lead a workplace diversity effort called OneTen.Credit…Mike Cohen for The New York Times

Jarred by the death of George Floyd and the issues of racial injustice raised in its wake, the chief executives of three dozen companies are starting an initiative to provide a million jobs for Black workers in the next decade.

The effort, called OneTen, is led by Merck’s chief executive, Kenneth C. Frazier, and IBM’s executive chairman, Ginni Rometty. It includes leaders at 37 companies like American Express, AT&T, Bank of America, Cisco, Delta Air Lines, General Motors, Johnson & Johnson, Nike, Stryker, Target and Wal-Mart.

The companies hope to draw in a more diverse community of workers through a recruiting start-up that will identify potential job applicants with the help of community colleges, nonprofit groups, and other organizations known for cultivating Black talent.

Organizers said the jobs would have a wide range, from nurse practitioners to roles relying on specialized technology skills. The hope, they said, is to put more Black employees into better-paying, more secure jobs that will help sustain working families and provide better access to the upper echelons of corporations.

“The primary creator of wealth in the United States is the private sector,” Mr. Frazier said. “We can rebuild our country coming out of this pandemic. And if private companies decide that they’re going to hire, as we rebuild our economy, with an equity lens, then we’ll change the country.”

Mr. Frazier, one of only a few chief executives in the Fortune 500 who is Black, said the OneTen effort began after the killing of Mr. Floyd last May by a Minneapolis police officer. The event set off angry protests over racial inequities and “soul searching” in corporate America as well, Mr. Frazier said.

Talking with other chief executives, business organizations and Ms. Rometty, who has emphasized the importance of a diverse work force at IBM, Mr. Frazier said he came to believe that, as employers, their best tool for combating systemic racism was to attract new Black talent into well-paying jobs at their companies. Given that only about 22 percent of Black people over the age of 25 in the United States have attained a bachelor’s degree — a markedly lower percentage than white and Asian people — Mr. Frazier and Ms. Rometty said that drawing more Black talent would probably require dropping certain college-education requirements.

“As an employer, if I state that every job has to have a college degree, I am predetermining the outcome,” said Ms. Rometty. “The talent is out there; I must find another pathway for it to come to me.”

OneTen — the name refers to hiring one million workers in 10 years — is set to begin its work in January. A chief executive has not yet been named.

Dr. Vivek H. Murthy advised the N.C.A.A. Board of Governors in the early days of the coronavirus pandemic.Credit…Hilary Swift for The New York Times

President-elect Joseph R. Biden Jr.’s choice for surgeon general, Dr. Vivek H. Murthy, had a central role in the National Collegiate Athletic Association’s decision in March to cancel this year’s national basketball tournaments — one of the earliest and most culturally significant signs that the virus would upend ordinary life in America.

The work of Dr. Murthy, a member of the association’s powerful Board of Governors who was surgeon general during part of the Obama administration, offers a view into how he approached the pandemic’s initial threat in the United States, and how he might help shape the federal government’s response under Mr. Biden.

A newcomer to the insular world of college athletics, Dr. Murthy proved a cautious, deliberate expert who was wary of making drastic decisions prematurely, interviews with more than a dozen people who participated in the N.C.A.A.’s meetings suggest. But they said that as the tournaments approached and more data and scientific research emerged, Dr. Murthy was a forceful and effective champion of measures that had been unthinkable to most of society only days or weeks earlier.

Indeed, it was Dr. Murthy who urgently told board members that they risked fueling a deadly crisis if they allowed the tournaments to proceed as scheduled.

“He was instrumental in convincing the board that the time to act was now,” said Kenneth I. Chenault, a former chairman of American Express who sits on the N.C.A.A. board.

But board members like Mr. Chenault said that it was plain that Dr. Murthy understood the cultural and financial repercussions of a decision like canceling the basketball tournaments, which generate hundreds of millions of dollars.

  • The Trump administration announced Wednesday that it was filing a challenge to measures that Canada uses to protect its dairy market, the first enforcement action taken under a new trade agreement that the countries agreed to last year. Under the terms of the United States-Mexico-Canada Agreement, which replaced the North American Free Trade Agreement this year, the United States and Canada will now enter consultations, and if the issue isn’t resolved the United States can request a special panel be formed to examine the matter.

  • Starbucks announced on Wednesday that Mellody Hobson will be the next non-executive chair of the company’s board, as the coffee chain moves closer to its goal of increasing diversity among its leadership. One of the most senior Black women in finance, Ms. Hobson has served on the board for 15 years and will step into the new role in March. She will replace Myron Ullman III, who has served as chair since 2018 and is retiring.

Categories
Business

Reside Market Updates: Shares Decline Amid Covid Restrictions and Rising Instances

Here’s what you need to know:

Credit…Andrew Testa for The New York Times

Businesses in Britain and the European Union are bracing for the economic disruption of Brexit, which threatens to clog ports and disrupt trade across the English Channel on Dec. 31 if leaders do not reach a compromise to settle their future trading relationship.

But the economic breakup could have a relatively limited impact on trade with the United States, trade experts said.

Because the United States does not have a free-trade agreement with the European Union, Britain’s departure from the bloc will do little to alter its trading relationship with the United States. Following Brexit, the terms of trade between the United States and Britain will continue to be governed by the rules of the World Trade Organization, as they were before.

The direct effect on the two trade partners “should be minimal given there’s no change in tariffs,” said Christopher Rogers, a global trade and logistics analyst at Panjiva.

Still, he said, significant customs disruptions between Europe and Britain could have knock-on effects for supply chains, if, for example, it takes British businesses that are exporting to the United States longer to source components from abroad. Goods are piling up at some British ports, as trucks and rail have failed to keep up with companies trying to stockpile ahead of Brexit.

Britain’s trading terms with the United States may not get much worse, but they also appear unlikely to get better.

The two countries have been carrying out negotiations for a free-trade deal since May. But with the election of Joseph R. Biden Jr., the prospects for that agreement, which many Britons saw as a source of post-Brexit strength, have been greatly diminished.

The congressional authority that gives trade deals an easier path to approval by Congress, called trade promotion authority, is set to expire this summer, and Mr. Biden has promised not to enter into any major new trade agreements until the United States has made major investments at home.

Boeing 737 Max aircraft in a lot at Boeing Field in Seattle. The plane was grounded worldwide almost two years ago.Credit…Lindsey Wasson/Reuters

Gol Airlines, a Brazilian carrier, said it planned to start flights aboard the Boeing 737 Max on Wednesday, making it the first airline to fly passengers on the plane since it was grounded worldwide almost two years ago.

The first flights will be on domestic routes to and from Gol’s hub in São Paulo, with the company expecting all seven of the Max planes in its fleet to be updated and cleared to fly by the end of the month. A Gol spokeswoman declined to provide further details.

“Our first priority is always the safety of our customers,” Celso Ferrer, vice president of operations and a commercial pilot at Gol, said in a statement. “Over the past 20 months, we have watched the most comprehensive safety review in the history of commercial aviation unfold.”

The Max was banned worldwide in March 2019 after a total of 346 people were killed in two crashes aboard the plane. In the United States, the Federal Aviation Administration last month became the first regulator to allow the plane to fly again, after required modifications are made. The agency was recently joined by regulators in Brazil, while the European aviation authority has suggested that it plans to lift its ban within weeks. Relatives of those killed in the crashes criticized the decision to allow the plane to fly again, arguing that it remains unsafe.

The lifting of the ban allows Boeing to restart sales and deliveries in earnest after its passenger airline business was pummeled by the grounding and the pandemic. The plane maker on Tuesday reported a net decline of 61 orders last month. Boeing’s backlog of orders, most of them for the Max, stood at 4,240, down more than a thousand from the start of the year after accounting for fulfilled orders.

Still, airlines are still interested in acquiring the plane. Last week, the company announced it had agreed to sell 75 Max jets to Ryanair, the low-cost European airline. Like RyanAir, Gol is among the biggest customers for the Max. The airline’s fleet is composed of 127 Boeing planes and it has an order for 95 Max jets scheduled for delivery over a decade starting in 2022.

Brian Chesky, Airbnb’s co-founder, in 2018. It’s usually not regular people, employees or even pre-I.P.O. investors who get a windfall from initial public offerings.Credit…Eric Risberg/Associated Press

A dirty secret of initial public offerings is that even the coolest ones may make only a handful of people rich — and it may not be regular people, employees or even fancy pre-I.P.O. investors who get a windfall.

DoorDash and Airbnb are expected to have spectacular first sales on public stock exchanges this week and start trading at far higher levels than anticipated even a few weeks ago.

But buying stock in relatively young and unproven companies — which usually describes technology companies selling their stock to the public for the first time — is often a coin-toss bet. Even the professional investors who buy stock in hot companies before they go public don’t always get rich, unless they throw their money around early and get lucky. Companies you might have heard of like Uber, Lyft, Snapchat and Slack were at best meh I.P.O. investments.

Look at Airbnb. Among the investors who got a special chance to buy Airbnb stock nearly four years ago, each $10,000 of stock they bought will be worth about $11,500 if Airbnb starts selling its shares to the public for $60 each. Nice!

But if your aunt had invested $10,000 nearly four years ago in a simple fund that mirrored the ups and downs of the S&P 500 stock index, she would now have $15,600. Even nicer.

The pandemic hurt business for Uber and Lyft, but their stocks were losers before then. Uber’s stock price has bounced back and is now up 30 percent since the spring, and still anyone who bought Uber shares in its 2019 I.P.O. — and even the professional investors who bought its stock in the four years before that — would have made far more money buying an index fund. Uber employees who were hired before the I.P.O. and were paid partly in stock also would have been better off getting paid in an index fund.

People who bought Snapchat’s stock in its 2017 initial public offering had to wait more than three years to not lose money on their bet. Slack just sold itself at a share price not much higher than its first public stock sale last year.

These are cherry-picked examples. There are companies whose stock prices have soared since their I.P.O.s and made people rich — Zoom Video is a prominent example in technology. And the people who have already bet on the restaurant delivery app DoorDash stand to make a big profit when the company goes public this week.

Will Airbnb be a winning I.P.O.? It depends. It definitely will be for the venture capital firm Sequoia, which bet on Airbnb early. And it’s certainly faring better than people expected when travel froze early this year. But no one can confidently predict whether its share price will shoot to the moon like Zoom’s has since its 2019 I.P.O. or will plunge as Lyft’s did after it went public.

That’s the lesson. Cool companies don’t always make good investments. The people screaming on Robinhood about their splurge on a hot I.P.O. may not know what they’re talking about.

By: Ella Koeze·Source: Refinitiv

  • Stocks were unsteady on Tuesday, as the spread of coronavirus cases and restrictions on people’s movement and businesses outweighed optimism about the rollout of a vaccine.

  • The S&P 500 was flat by midday after recovering from an earlier dip. The Stoxx Europe 600 and Britain’s FTSE 100 also recouped small losses and were slightly higher.

  • In the United States, rising numbers of virus cases has led California to impose new stay-at-home orders in large swathes of the state. In New York, the number of people hospitalized with the coronavirus is rising and could lead to another ban on indoor dining.

  • In Europe, countries are struggling to emerge from a second wave of the pandemic. The infection rate in France is threatening plans to ease restrictions before the holidays, and in Greece, the lockdown was extended until early January.

  • But on a brighter note, Britain on Tuesday started a mass vaccination campaign, delivering the first shots of the Pfizer-BioNTech Covid-19 vaccine. “There is finally some clear light at the end of a very dark tunnel,” James Pomeroy, an economist at HSBC, wrote in a note to clients. “And that cheer should be seen in some of the economic data in the coming year too.”

  • Tesla said on Tuesday it would sell as much as $5 billion in shares, its third return to markets in 10 months, and use the money for more investments including factory construction. Tesla’s shares were down nearly 3 percent. This year, the electric carmaker’s shares have risen about 670 percent, and later this month, the company will join the S&P 500.

Google’s offices in London. Britain’s top antitrust regulator recommended a new tech watchdog.Credit…Ben Stansall/Agence France-Presse — Getty Images

Governments around the world have been grappling with ways to crimp the power of the biggest tech companies. In the United States, the Justice Department recently filed an antitrust case against Google. The European Union has issued antitrust violations and enacted stiffer data-protection laws. The Australian government is pushing new rules to make Google and Facebook pay for certain content.

But many question whether the tactics are adequate, particularly if a lengthy enforcement and legal process slows down action against the fast-moving and deep-pocketed companies.

On Tuesday, Britain’s top antitrust regulator recommended a new approach. The Competition and Markets Authority released recommendations for creating a new regulator called the Digital Markets Unit that will focus on the biggest technology platforms. The regulator would be able to fine companies up to 10 percent of global revenue.

The idea of creating a tech industry regulator has gained momentum among academics and policymakers around the world. The aim is to treat giants like Amazon, Apple, Facebook, Google, and Microsoft more like the biggest companies in banking and health care — with dedicated regulators that have the expertise in the subject matter to serve as a watchdog and act quickly to address wrongdoing, akin to the Securities and Exchange Commission and the Food and Drug Administration.

Britain is perhaps the furthest along. The new regulator would be responsible for enforcing a legally binding code of conduct intended to prevent the biggest companies from using their dominance to exploit consumers and business, or to box out emerging competitors. Officials said only companies of a certain size would fall under the rules, which would be tailored to specific types of businesses. Google and Facebook may face certain restrictions related to digital advertising, while Amazon would have others related to e-commerce.

To improve competition, the regulator could force companies to share certain data with rivals, and it would review acquisitions.

The proposals build on recommendations made by a British panel of experts last year and are part of a process by the government to enact regulations for the digital economy by next year. Britain is preparing to leave the European Union, which next week will release its own draft laws to increase oversight of the tech industry across the 27-nation bloc.

British authorities have raised specific concerns about the digital advertising market dominated by Google and Facebook. In July, the Competition and Markets Authority published a 437-page investigation that concluded the two companies have such scale and unmatched access to user data that “potential rivals can no longer compete on equal terms.”

Goldman Sachs has reached a deal to buy out the minority partner in its Chinese securities joint venture, which could make it the first global bank to assume full ownership of its securities business in mainland China since the Communist Party took control of foreign-owned enterprises in the country in the 1950s.

In a memo to employees on Tuesday, the Wall Street bank said it had reached a definitive agreement to buy a 49 percent stake in Goldman Sachs Gao Hua still held by its local partner, Beijing Gao Hua Securities. Goldman Sachs did not disclose a price for the transaction.

The deal follows a pledge by Chinese leaders in 2017, amid worsening trade relations with the United States, to relax or remove limits on foreign bank ownership. The move was part of an unsuccessful effort by China to enlist Wall Street in heading off President Trump’s plans to impose tariffs on Chinese goods.

Goldman Sachs could be the first to take full control of its China securities business, depending on regulatory approval and how quickly the deal is completed.

JP Morgan Chase already has full ownership of its futures business in China, but still has a joint venture for other activities on the mainland. Other investment banks, like JP Morgan Chase, Morgan Stanley, UBS and Nomura, are in various stages of raising their stakes in their Chinese securities operations.

Commercial banks, by contrast, have avoided raising their stakes in commercial banking operations in mainland China above 25 percent. Doing so would subject those operations to further global banking regulations.

Goldman Sachs had announced on March 27 that it had obtained regulatory approval to raise its stake in Goldman Sachs Gao Hua from 33 percent to 51 percent. Tuesday’s memo was reported earlier by The Wall Street Journal.

With movie theaters largely shut across the United States, traditional movie companies like Warner Bros. are being forced to evolve.Credit…Aaron P/Bauer-Griffin, via Getty

Last week, when Jason Kilar, WarnerMedia’s chief executive, announced that 17 more Warner Bros. movies would each roll out on HBO Max and in theaters simultaneously. To prevent the news of the 17-movie shift from leaking (and to make the move speedily rather than get mired in the expected blowback), WarnerMedia kept the major agencies and talent management companies in the dark until roughly 90 minutes before issuing a news release, report Brooks Barnes and Nicole Sperling.

The surprise move left agencies on a war footing. Representatives for major Warner Bros. Talk of a Warner Bros. boycott began circulating inside the Directors Guild of America. A partner at one talent agency spent part of the weekend meeting with litigators. Some people started to angrily refer to the studio as Former Bros.

The 97-year-old studio, the ancestral home of Humphrey Bogart (“Casablanca”) and Bette Davis (“Now, Voyager”), suddenly finds itself at the uncomfortable center of a Hollywood that is changing at light speed. Even before the pandemic, streaming services like Netflix, Apple TV+ and Amazon Prime Video were upending how movies get seen and their creators are compensated. Now, with theaters struggling because of the coronavirus and the public largely stuck at home, even traditional film companies are being forced to evolve.

It’s not that all actors and directors are against streaming. Plenty of big names are making movies for Netflix. But last week’s move by Warner Bros. raised fundamental financial questions. If old-line studios are no longer trying to maximize the box office for each film but instead shifting to a hybrid model where success is judged partly by ticket sales and partly by the number of streaming subscriptions sold, what does that mean for talent pay packages?

How studios compensate A-list actors, directors, writers and producers is complicated, with contracts negotiated film by film and person by person. But it boils down to two checks. One is guaranteed (a large upfront fee) and one is a gamble: a portion of ticket sales after the studio has recouped its costs.

If a film flops, the second payday never comes. If a film is a hit, as is often the case with superheroes and other fantasy stories, the “back end” pay can add up to wheelbarrows full of cash.

A garage at the Aurora office in Palo Alto, Calif.Credit…Jason Henry for The New York Times

Uber, which spent hundreds of millions of dollars on a self-driving car project that executives once believed was a key to becoming profitable, is handing the autonomous vehicle effort over to a Silicon Valley start-up, the companies said on Monday.

Uber will also invest $400 million in the start-up, called Aurora, so it is essentially paying the company to take over the autonomous car operation, which had become a financial and legal headache. Uber is likely to license whatever technology Aurora manages to create.

The deal amounts to a fire-sale end to a high-profile but star-crossed effort to replace Uber’s human drivers with machines that could drive on their own. It is also indicative of the challenges facing other autonomous vehicle projects, which have received billions in investments from Silicon Valley and automakers but have not produced the fleets of robotic vehicles some thought would be on the streets by now.

Aurora’s chief executive, Chris Urmson, said Aurora’s first product will not be a robot taxi that could help with Uber’s ride-hailing business. Instead, it will likely be a self-driving truck, which Mr. Urmson believes has a better chance of success in the near term because long-haul truck driving on highways is more predictable and does not involve passengers.

In a statement, the Uber chief executive, Dara Khosrowshahi, said he was looking forward to bringing Aurora technology to market “in the years ahead.” Uber declined to comment further on the agreement.

  • Rashida Jones, a senior vice president for news at MSNBC and NBC News, will become the first Black woman to take charge of a major television news network. Her promotion, announced by Cesar Conde, the chairman of NBCUniversal News Group, is another big shake-up in the network’s management ranks. She will succeed Phil Griffin, the MSNBC president whose left-leaning shows yielded big ratings in the Trump years and minted media brands like “The Rachel Maddow Show” and “Morning Joe,” will depart on Feb. 1 after a 12-year tenure, the network said on Monday.

  • The Japanese advertising giant Dentsu Group plans to cut roughly 6,000 jobs as it grapples with the effects of the coronavirus pandemic. In a securities filing in Tokyo on Monday, Dentsu laid out details of its restructuring strategy, which will cost 88 billion yen (about $850 million) to carry out over two years and includes trimming its 48,000-person international work force by 12.5 percent. The timeline will vary by location, the company said.

Patrick Gaspard, a former aide to President Barack Obama, U.S. ambassador to South Africa and executive director of the Democratic National Committee, has emerged as the leading candidate to be nominated as labor secretary under President-elect Joseph R. Biden Jr., according to people with knowledge of the discussions.

Mr. Gaspard announced last week that he would step down as the head of the Open Society Foundations, founded by the liberal megadonor George Soros, at the end of the year, fueling speculation in Washington that he was poised to join the incoming administration. He has a background in labor organizing, including a senior leadership position for the Service Employees International Union, which he held before joining the Obama administration.

His potential nomination would give Mr. Biden, who calls himself a “union guy,” a labor secretary with union roots. He would also add to the list of Black cabinet appointees, a key goal of Mr. Biden’s transition team as it seeks to fulfill Mr. Biden’s campaign promise of diversity in the top leadership of his administration.

Born in the Democratic Republic of Congo to Haitian parents, Mr. Gaspard immigrated to the United States in early childhood, grew up in New York and attended Columbia University before leaving to work on Jesse Jackson’s 1988 presidential campaign. He worked for years in New York City politics and on Howard Dean’s 2004 Democratic presidential bid, and he was an aide to former Mayor David Dinkins. After Mr. Dinkins died last month, Mr. Gaspard wrote on Twitter, “He taught me that you don’t need to be loud to be strong.”

Mr. Gaspard worked for years as an organizer and rose through the Service Employees International Union to become its national political director before joining Mr. Obama’s 2008 presidential campaign. In the Obama White House, Mr. Gaspard served as director of political affairs, before helming the Democratic National Committee and being confirmed as Mr. Obama’s ambassador to South Africa.

Allies of Senator Bernie Sanders, independent of Vermont and Mr. Biden’s chief rival for the Democratic nomination this year, had pushed hard for Mr. Sanders to be selected as labor secretary. But Mr. Biden’s short list for the job does not appear to include Mr. Sanders.

Categories
World News

Covid-19 Information: Dwell Updates – The New York Occasions

Here’s what you need to know:

Video

transcript

Back

transcript

‘Go for It’: U.K.’s First Vaccine Patient Encourages Others

Margaret Keenan, the first patient in Britain to receive the coronavirus vaccine, hopes to set an example for people hesitant to get vaccinated.

It was fine, it was fine. I wasn’t nervous at all. It was really good. “And what do you say to those who might be having second thoughts about this?” Well, I would say go for it. Go for it, because it’s free and it’s the best thing that’s ever happened, at the moment. So, do please go for it. That’s all I’ll say, you know. If I can do it, well, so can you.

Margaret Keenan, the first patient in Britain to receive the coronavirus vaccine, hopes to set an example for people hesitant to get vaccinated.CreditCredit…Pool photo by Jacob King

Britain’s National Health Service delivered its first shots of the Pfizer-BioNTech Covid-19 vaccine on Tuesday, opening a mass vaccination campaign with little precedent in modern medicine and making Britons the first people in the world to receive a clinically authorized, fully tested vaccine for the disease.

Across the nation, vaccine centers are beginning the careful process of delivering vaccinations on a tight schedule, as the vaccine must be used or discarded within five days of being defrosted. “We’re doing it with military precision, and in fact, we have had the military helping with our planning too,” said Fiona Kinghorn, who oversaw the vaccine rollout at one site in Cardiff, Wales.

The effort marks a turning point in the remarkable race to produce a vaccine and the global effort to end a pandemic that has killed 1.5 million people worldwide. At one Welsh vaccination center, a retired nurse on the facility staff described the response by her most recent patient, another nurse. “She just cried and said this was such an emotional day,” she said, adding: “I think partly because she worked on a Covid ward, so she has seen the consequences and probably the outcomes. I presume she has seen a lot.”

At 6:31 a.m. Tuesday, Margaret Keenan, 90, a former jewelry shop assistant, rolled up the sleeve of her “Merry Christmas” T-shirt to receive the first shot, and her image quickly became an emblem of hope and resilience.

“I feel so privileged to be the first person vaccinated against Covid-19,” said Ms. Keenan, who lives in Coventry, in central England. “It means I can finally look forward to spending time with my family and friends in the new year after being on my own for most of the year.”

British regulators leapt ahead of their American counterparts last week to authorize a coronavirus vaccine, upsetting the White House and setting off a spirited debate about whether Britain had moved too hastily, or if the United States was wasting valuable time as the virus was killing about 2,200 Americans a day over the last week, as of Monday.

President Trump planned on Tuesday to issue an executive order proclaiming that other nations will not get U.S. supplies of its vaccine until Americans have been inoculated, a directive that appeared to have no real teeth but nevertheless was indicative of the heated race to secure shipments of doses.

For the people receiving vaccinations in Britain, among them doctors and nurses who have fortified the country’s National Health Service this year, the shots were an early glimpse at post-pandemic life. Besides Ms. Keenan, none attracted as much attention as William Shakespeare, who was second in line for a shot in Coventry and who, the National Health Service confirmed, really is named William Shakespeare. Twitter took the news of his vaccination as an opportunity for delighted wordplay, cracking jokes about the Taming of the Flu and the Gentlemen of Corona.

“Today is a great day for medical science, and the future,” Chris Whitty, the chief medical officer for England, said on Tuesday. (An earlier version of this item mistakenly said he was the chief medical officer for all of Britain.)

The first 800,000 doses of the Pfizer-BioNTech vaccine for Britain were transported in recent days from a manufacturing plant in Belgium to government warehouses in Britain, and then to hospitals.

Fifty hospitals will be administering the shots until the government can refine a plan for delivering them at nursing homes and doctor’s offices. The vaccine must be transported at South Pole-like temperatures before it can be stored for five days in a normal refrigerator, Pfizer has said. First to receive the vaccine will be doctors and nurses, certain people aged 80 and over, and nursing home workers.

Some doctors and nurses have received invitations in recent days to sign up for appointments, with the first shots intended for those at the highest risk of severe illness. The government has indicated that people aged 80 and over who already have visits with doctors scheduled for this week, or who are being discharged from certain hospitals, will also be among the first to receive shots.

Nursing home residents, who were supposed to be the government’s top priority, will be vaccinated in the coming weeks, once health officials start distributing doses beyond hospitals.

Hundreds of people are still dying in Britain each day from the virus, and the country has made allowances for travel over the Christmas period that scientists fear will seed another uptick in infections.

“It is amazing to see the vaccine, but we can’t afford to relax now,” Prime Minister Boris Johnson of Britain said on Tuesday morning as he visited a London hospital. Trying to calm a recipient’s nerves about needles, he suggested, “I always try to think of something else — recite some poetry.”

Ms. Keenan, the first vaccine recipient, showed no such nerves. Nicola Sturgeon, Scotland’s first minister, said on Twitter that watching Ms. Keenan receive the shot gave her “a bit of a lump in the throat.”

“Feels like such a milestone moment after a tough year for everyone,” Ms. Sturgeon added.

Administering Ms. Keenan’s shot was May Parsons, a nurse who is originally from the Philippines and has worked for the National Health Service for 24 years.

“The last few months have been tough for all of us working in the N.H.S.,” she said, “but now it feels like there is light at the end of the tunnel.”

An Oxford Vaccine Group researcher in a laboratory in Oxford, England, working on the coronavirus vaccine developed by AstraZeneca and Oxford University.Credit…John Cairns/University of Oxford, via Associated Press

The University of Oxford published a much-anticipated paper on Tuesday detailing the findings of its coronavirus vaccine trials, echoing results first announced two weeks ago that showed the vaccine had 70 percent efficacy on average across two different dosing regimens.

But while it was the first peer-reviewed publication outlining late-stage results of a leading coronavirus vaccine, it did little to answer the most pressing questions facing the university and AstraZeneca, the drug maker, since they offered a glimpse at the same promising, if somewhat puzzling, results two weeks ago.

Among nearly 8,900 participants who received two full doses of the vaccine, it had 62 percent efficacy. But after a discrepancy over methods for measuring the concentration of viral particles in the vaccine created uncertainty over the dosage during an early stage of manufacturing, 2,741 participants were given a half dose of the vaccine followed a month later by a full dose. In that smaller group of participants, the vaccine had 90 percent efficacy.

The Oxford scientists said in the paper, published in the Lancet, a British medical journal, that “further work is needed to determine the mechanism of the increased efficacy.”

Both dosing regimens appeared to protect participants in the trials from hospitalization or severe disease.

The results combined data from a trial in Brazil with a trial in Britain. In the British trial, the researchers asked participants to swab their noses and throats weekly to test for asymptomatic infections, a way of determining whether the vaccine could protect not only against disease but also transmission.

The vaccine appeared to be more effective in protecting against asymptomatic infections in the low-dose, high-dose regimen, but the numbers were so small that it was difficult to be sure. The researchers wrote in the paper that the results “provide some hope that Covid-19 vaccines might be able to interrupt some asymptomatic transmission,” though they said “more data are needed to confirm.”

Jenna Ellis and Rudolph W. Giuliani, members of President Trump’s legal team, appearing before the Michigan House Oversight Committee in Lansing, Mich., last week.Credit…Rey Del Rio/Getty Images

Jenna Ellis, a senior legal adviser to President Trump, has tested positive for the coronavirus, according to a White House official familiar with the situation. She is the latest in a string of officials connected to Mr. Trump who have tested positive.

Ms. Ellis has appeared in recent weeks alongside Rudolph W. Giuliani and other Trump lawyers — a group Ms. Ellis has described as an “elite strike-force team” — at public hearings where she amplified the president’s false claims of widespread voter fraud.

Mr. Giuliani, the lead lawyer for the president’s efforts to overthrow the results of the election, confirmed over the weekend that he had tested positive for the virus, and a person who was aware of his condition but not authorized to speak publicly said then that he had been hospitalized at Georgetown University Medical. At age 76, Mr. Giuliani is in a high-risk category. Mr. Trump said on Monday that he had spoken to Mr. Giuliani and he was doing “very well.”

Ms. Ellis was photographed last week, on Wednesday, sitting next to Mr. Giuliani during a hearing before the Michigan House Oversight Committee. It was not immediately clear whether she had any symptoms, or what kind of test she had taken. Ms. Ellis continued to post to Twitter throughout the day on Tuesday, including sharing a statement attributed to her and Mr. Giuliani about their legal efforts. She did not respond to a message seeking comment.

Ms. Ellis has been a frequent guest on cable news, where she aggressively defended Mr. Trump as he faced investigation and impeachment. She presents herself as a constitutional law attorney, but has never appeared in federal district or circuit court, where most constitutional matters are considered, according to national databases of federal cases. She does not appear to have played a major role in any cases beyond criminal and civil work in Colorado.

Ms. Ellis’s most recent work appears to have been largely in a public-relations capacity. The Trump campaign and its supporters have so far filed about 50 election-related lawsuits. She has not signed her name or appeared in court to argue a single one.

At least 40 members of Mr. Trump’s administration, campaign and inner circle have contracted the virus since late September. In early October, Mr. Trump was hospitalized for a few days after testing positive and developing symptoms of Covid-19.

The Pfizer-BioNTech vaccine was prepared in a pharmacy at the Cardiff and Vale Therapy Center in Cardiff, Wales, on Tuesday.Credit…Andrew Testa for The New York Times

The complicated logistics at one vaccination center offer insights into the challenges ahead for a mass rollout of the new inoculation program across Britain. While the country has been getting ready for a vaccine for some time, only now are the difficulties involved in a program of this scale being fully understood.

Fiona Kinghorn, executive director of public health for the Cardiff and Vale University Health Board, who oversaw the vaccine rollout at one site in Cardiff, the capital of Wales, said setting up the center and delivering the first shots on Tuesday was a major undertaking.

“It’s not just this week, it’s been six months of work,” she said.

Work on a mass vaccination program began in earnest in June, long before it was clear which vaccine might be approved by the government and when. On Monday, the center received one batch of vaccine — a tray of vials containing 975 doses, five to each vial — that must be used within five days after being defrosted.

“We’ve had to prioritize and phase how we might bring people in,” she said. The center began with health care workers and social care staff.

Unlike flu vaccines, which come prepacked in syringes for easy use, the coronavirus vaccines must be prepared on site after they are defrosted, and then the prepared vials must be used within hours. The center was scheduled to provide 225 vaccinations on Tuesday and continue daily until they finish the tray. Any doses they failed to use in time would have to be discarded, creating a sense of urgency.

“We’re doing it with military precision, and in fact, we have had the military helping with our planning too,” Ms. Kinghorn said.

The center will receive its next tray of vaccine on Friday, and then will decide on the right time to defrost and begin using those.

In Cardiff, Wales, a former gymnasium was turned into a vaccination site.Credit…Andrew Testa for The New York Times

Britain’s National Health Service began delivering shots of the Pfizer-BioNTech vaccine on Tuesday, opening a public health campaign with little precedent in modern medicine.

Here is a guide to some of the basics.

Britain’s drug regulator is seen as a bellwether agency, and its decisions often have influence abroad. In the case of the Pfizer vaccine, the agency has said that it did not cut any corners and undertook the same laborious process of vetting the quality, efficacy and manufacturing protocols of the vaccine.

Dr. Anthony S. Fauci, the United States’s top infectious disease expert, said last week that the British had not reviewed the vaccine “as carefully” as the United States was. But he walked back those comments the next day, saying: “I have a great deal of confidence in what the U.K. does both scientifically and from a regulator standpoint.”

Doctors and nurses, certain people 80 or over and nursing home workers.

Life will return to normal only when society as a whole gains enough protection against the coronavirus. Once countries authorize a vaccine, they’ll be able to vaccinate only a small percentage of their citizens in the first couple of months.

Once enough people get vaccinated, it will become very difficult for the virus to find vulnerable people to infect. Life may start approaching something like normal by the fall of 2021.

Yes, but not forever. The two vaccines that will potentially get authorized this month protect people from getting sick with Covid-19. But the clinical trials that delivered these results were not designed to determine whether vaccinated people could still spread the virus without developing symptoms.

The Pfizer and BioNTech vaccine is delivered as a shot in the arm, like other typical vaccines. The injection won’t be any different from ones you’ve gotten before. Tens of thousands of people have already received the vaccines, and none of them have reported any serious side effects. Some have felt aches and flulike symptoms that last less than a day.

There’s no evidence that it does, and there’s good reason to think that it does not.

Some claims have been floating around the web that coronavirus vaccines can harm a woman’s fertility. The supposed evidence rests on the fact that most coronavirus vaccines work by creating antibodies that attack the virus’s “spike” protein, and this protein has a minor resemblance to a protein crucial for the formation of the placenta.

But that does not mean that the antibodies generated by coronavirus vaccines would attack a pregnant woman’s placenta. The region of the placental protein that’s similar to spike is just too short to give the antibodies a grip.

A vial of the Pfizer-BioNTech COVID-19 vaccine at the Royal Victoria Hospital in Belfast, Northern Ireland, on Tuesday.Credit…Pool photo by Liam McBurney

The coronavirus vaccine made by Pfizer and BioNTech provides strong protection against Covid-19 within about 10 days of the first dose, according to documents published on Tuesday by the Food and Drug Administration before a meeting of its vaccine advisory group.

The finding is one of several significant new results featured in the briefing materials, which span 53 pages of data analyses from the agency. Last month, Pfizer and BioNTech announced that their two-dose vaccine had an efficacy rate of 95 percent after two doses administered three weeks apart. The new analyses show that the protection starts kicking in far earlier.

What’s more, the vaccine worked well regardless of a volunteer’s race, weight or age. While the trial did not find any serious adverse events caused by the vaccine, many participants did experience aches, fevers and other side effects.

On Thursday, the F.D.A.’s vaccine advisory panel will discuss these materials in advance of a vote on whether to recommend authorization of Pfizer and BioNTech’s vaccine.

Despite the early protection afforded by the first dose, it’s unclear how long that protection would last on its own, underscoring the importance of the second dose. Previous studies have found that the second dose of the Pfizer-BioNTech vaccine gives the immune system a major, long-term boost, an effect seen in many other vaccines.

Many experts have expressed concern that the coronavirus vaccines might protect some people better than others. But the results in the briefing materials indicate no such problem. The vaccine has a high efficacy rate in both men and women, as well as similar rates in white, Black and Latino people. It also worked well in obese people, who carry a greater risk of getting sick with Covid-19.

A free Covid-19 testing site in the Bronx, New York City. Some states, including New York, are pushing back on the agreement to share data of people being vaccinated.Credit…James Estrin/The New York Times

The Trump administration is requiring states to submit personal information of people vaccinated against Covid-19 — including names, birth dates, ethnicities and addresses — raising alarms among state officials who fear that a federal vaccine registry could be misused.

The Centers for Disease Control and Prevention is instructing states to sign so-called data use agreements that commit them for the first time to sharing personal information in existing registries with the federal government. Some states, such as New York, are pushing back, either refusing to sign or signing while refusing to share the information.

Gov. Andrew M. Cuomo of New York warned that the collection of personal data could dissuade undocumented people from participating in the vaccination program. He called it “another example of them trying to extort the State of New York to get information that they can use at the Department of Homeland Security and ICE that they’ll use to deport people.”

Administration officials say that the information will not be shared with other federal agencies and that it is needed for several reasons: to ensure that people who move across state lines receive their follow-up doses; to track adverse reactions and address safety issues; and to assess the effectiveness of the vaccine among different demographic groups.

At a briefing with a small group of reporters on Monday, officials from Operation Warp Speed, the government’s vaccine initiative, defended the plan. They said all but a handful of states had signed data agreements, and the rest would sign by the end of the week, though it is not clear how many states will submit personal information.

“There is no social security number being asked for, there is no driver’s license number,” said Deacon Maddox, who runs the operation’s data and analysis system. “The only number I would say that is asked is the date of birth.”

The hurried effort at data gathering, with delivery of vaccine doses expected to begin next week, is making many immunization experts deeply uneasy. At issue is the delicate balance between a patient’s right to privacy and the government’s right to invoke its expansive authority in the name of ending the deadliest pandemic in more than a century.

Video

transcript

Back

transcript

William Shakespeare Receives Coronavirus Vaccine in Britain

In Coventry, England, on Tuesday, a man named William Shakespeare, 81, joined Margaret Keenan, 90, as a recipient of the new coronavirus vaccine.

“I hear your having an an injection then, OK?” “OK.” “I’ll speak to you soon. Do you want me to look after these?” “Yes.” “OK.”

Video player loadingIn Coventry, England, on Tuesday, a man named William Shakespeare, 81, joined Margaret Keenan, 90, as a recipient of the new coronavirus vaccine.CreditCredit…Pool photo by Jacob King

The world may be a stage, but William Shakespeare from Warwickshire didn’t flinch or shy away from his task: As Britain started to roll out the coronavirus vaccine on Tuesday, Mr. Shakespeare became the second person in the country to receive the vaccine outside a clinical trial

“It could make a difference to our lives from now on, couldn’t it?” Mr. Shakespeare, 81, said with a smile shortly after being vaccinated at University Hospital Coventry, in central England, just 20 miles north of where the man for whom he was named was born in 1564.

That one of the first recipients of the vaccine bore such a famous name — a fact that was confirmed by the National Health Service — brought surprise and lighthearted jokes, at a time when Britain faces the daunting task of mounting the largest vaccination campaign in its history.

“Shakespeare gets Covid vaccine,” the BBC wrote as a headline. Shakespeare’s comedy “The Taming of the Shrew” became The Taming of the Flu. And “The Two Gentlemen of Verona” quickly turned into The Gentlemen of Corona.

In a reference to Hamlet, one user wrote on Twitter, “If Margaret Keenan is patient 1A for the vaccine, would William Shakespeare be 2B, or not 2B … ,” about the first two patients to receive the vaccine.

Even Britain’s theaters weighed in.

Casting director: So what would you bring to the role of second patient? We want a sense of real drama and patriotism here.

Auditionee: I’m literally called William Shakespeare.

Casting director: Fair enough, the part’s yours. https://t.co/phnYvq0SSh

— Is it the National Theatre? Oh yes it is (@NationalTheatre) December 8, 2020

Mr. Shakespeare, who has been hospitalized in Coventry for several weeks after a stroke, received the shot in his left arm on Tuesday morning, wearing a hospital gown and bright red socks. He felt a little frail and took a nap in the afternoon, according to his niece, Emily Shakespeare.

“He’s delighted with it,” Ms. Shakespeare said in a telephone interview about her uncle’s first injection. “He’s dying to come home.”

Countless families around the world have been unable to visit relatives in nursing homes or hospitals during the pandemic, leaving many patients to suffer loneliness, atrophy and depression. Others died alone, and families never got to say goodbye.

So Mr. Shakespeare’s vaccination brought a bit of heartwarming news for people in Britain, and for his family. Within a few hours on Tuesday, he and Ms. Keenan had become the face of the country’s resilience against a virus that has killed more people in Britain than anywhere else in Europe.

“He is fed up being in the hospital,” Ms. Shakespeare said of her uncle, “but today I just want to say that I’m proud that he’s leading the way.”

She said it was “highly likely” that her uncle was related to “the” William Shakespeare, who died in 1616; she has traced his lineage back to the early 1700s, she said, but had more research still to do.

Britain’s health secretary, Matt Hancock, appeared to shed some tears on ITV as he heard the name of the first man in the country to receive the vaccine, which surely made Mr. Shakespeare raise an eyebrow, his niece said. “He’s left-leaning, so I’m not entirely sure how he feels about it,” Ms. Shakespeare added about the reaction from Mr. Hancock, a conservative.

May Parsons, the nurse who vaccinated Mr. Shakespeare and Ms. Keenan, said the injections were a first step in giving more people a sense of normality. “This is really important for me, knowing that they’re going to be safe, that they’re going to be protected,” Ms. Parsons told Sky News.

Unsurprisingly, Mr. Shakespeare’s name has brought him little moments of fame before, like the time in the 1960s when he was pulled over for speeding in Stratford-upon-Avon and the police officer did not believe it was his real name, Ms. Shakespeare said. “But this one goes beyond what he’s seen in the past,” she said.

It is also likely that another William Shakespeare will be vaccinated next year: Mr. Shakespeare’s 41-year-old son is also called William.

Ms. Shakespeare said the family wanted to remind everyone that there was much more at stake than the ephemeral fame of “their” William Shakespeare.

“He wants to to see his wife, his children and his grandchildren, who can’t visit him at the moment,” she said. “But the outpouring of attention will surely give him a boost.”

The Trump administration is said to have turned down an offer from Pfizer to purchase additional doses of its vaccine. Credit…Doug Mills/The New York Times

Before Pfizer’s coronavirus vaccine was proved highly successful in clinical trials last month, the company offered the Trump administration the chance to lock in supplies beyond the 100 million doses the pharmaceutical maker agreed to sell the government as part of a $1.95 billion deal months ago.

But the administration, according to people familiar with the talks, never made the deal, a choice that now raises questions about whether the United States allowed other countries to take its place in line.

As the administration scrambles to try to purchase more doses of the vaccine, President Trump plans on Tuesday to issue an executive order that proclaims that other nations will not get the U.S. supplies of its vaccine until Americans have been inoculated.

But the order appears to have no real teeth and does not expand the U.S. supply of doses, according to a description of the order on Monday by senior administration officials.

The vaccine being produced by Pfizer and its German partner, BioNTech, is a two-dose treatment, meaning that 100 million doses is enough to vaccinate only 50 million Americans. The vaccine is expected to receive authorization for emergency use in the U.S. as soon as this weekend, with another vaccine, developed by Moderna, also likely to be approved for emergency use soon.

Britain plans to begin a vaccination drive on Tuesday using the Pfizer-BioNTech vaccine, making it the first Western nation to start mass vaccinations.

On Nov. 11 — two days after Pfizer first announced early results indicating that its vaccine was more than 90 percent effective — the European Union announced that it had finalized a supply deal with Pfizer and BioNTech for 200 million doses, a deal they began negotiating in months earlier. Shipments could begin by the end of the year, and the contract includes an option for 100 million more doses.

Asked if the Trump administration had missed a crucial chance to snap up more doses for Americans, a spokeswoman for the Department of Health and Human Services said, “We are confident that we will have 100 million doses of Pfizer’s vaccine as agreed to in our contract, and beyond that, we have five other vaccine candidates.”

The government was in July given the option to request 100 million to 500 million additional doses. But despite repeated warnings from Pfizer officials that demand could vastly outstrip supply and amid urges to pre-order more doses, the Trump administration turned down the offer, according to several people familiar with the discussions.

In a statement, Pfizer said that “any additional doses beyond the 100 million are subject to a separate and mutually acceptable agreement,” and that “the company is not able to comment on any confidential discussions that may be taking place with the U.S. government.”

The bulk of the global supply of vaccines has already been claimed by wealthy countries like the United States, Canada, Britain and countries in Europe, leading to criticism that people in low- and middle-income countries will be left behind. The United States has declined to participate in a global initiative, called Covax, that is meant to make a vaccine available globally.

The decision to issue the executive order was reported earlier by Fox News.

Global Roundup

Pope Francis during the prayer for the feast of the Immaculate Conception in Piazza di Spagna in Rome on Tuesday.Credit…The Vatican Media, via EPA, via Shutterstock

Pope Francis canceled the traditional Dec. 8 papal visit to a Rome landmark because of social distancing concerns, he said on Tuesday. The afternoon event, observing the feast of the Immaculate Conception of the Virgin Mary, normally draws thousands of people.

“The traditional homage” did not take place, “to avoid the risk of crowds, as ordered by civil authorities, who we must obey,” Francis told the faithful who gathered in St. Peter’s Square for the Angelus prayer. Instead, the pope went to the site unannounced at 7 a.m., and left a bouquet of roses at the base of a column near the Spanish Steps that is topped by a statue of the Virgin Mary.

Other than in September and October, when new coronavirus cases in Italy appeared to have dropped significantly, Pope Francis has canceled most of his regular public appearances during the pandemic, so that crowds would not gather to see him. In their place, he has been streaming events online from the Apostolic Library in the Vatican. But he still appears every week at a window overlooking St. Peter’s Square to pray with and bless socially distanced worshipers below in the square.

Late last month, though, the pope did meet with a delegation of five N.B.A. players and officials from the players’ association privately at the Vatican to discuss their efforts to address social justice and economic inequality.

In other developments around the world

  • Hong Kong said it would once again ban restaurant dining after 6 p.m., and close all gyms and beauty salons, to help curb a rise in virus cases, Reuters reported. Health authorities said on Tuesday that people arriving in Hong Kong, who already must be tested on arrival and toward the end of the mandatory two-week quarantine, would also be required to be tested a third time three weeks after arrival. Hong Kong recorded 78 new cases on Monday, raising its total for the pandemic to 6,976 — tiny figures compared with most large Western countries, but a sign that even places that have been able to keep a tight lid on the virus are facing problems now.

  • Australia, where coronavirus cases are low, extended for another three months its ban on residents leaving the country, official said Tuesday. The country, which has some of the tightest restrictions anywhere, also extended its ban on cruise ships until March.

  • Chile announced new measures for Santiago, the capital, this week that are meant to avoid a total lockdown, the authorities said. The new restrictions include a full lockdown on weekends and lesser limitations during the week. The capital region reported an 18 percent increase in new cases last week, which “is shocking and worries us a lot,” said Enrique Paris, the health minister.

  • Four lions at the Barcelona Zoo have tested positive for the coronavirus, officials in Barcelona said Tuesday. The lions — three females and a male — were tested after showing symptoms, and were treated with anti-inflammatory drugs. Two employees also tested positive, officials said. It is the second known instance involving large felines: several lions and tigers at the Bronx Zoo in New York tested positive in April.

Last year’s Ohio State-Michigan game in Ann Arbor, Mich.Credit…Leon Halip/Getty Images

One of the biggest rites of college football — the annual Michigan-Ohio State game — is off for this weekend because of the coronavirus pandemic.

Michigan said Tuesday that it would be unable to play at fourth-ranked Ohio State on Saturday because of the number of virus cases inside its football program.

“The number of positive tests has continued to trend in an upward direction over the last seven days,” Warde Manuel, Michigan’s athletic director, said in a statement. “We have not been cleared to participate in practice at this time. Unfortunately, we will not be able to field a team due to Covid-19 positives and the associated quarantining required of close contact individuals.”

The cancellation raised the possibility that Ohio State (5-0) would prove ineligible for the Big Ten championship game on Dec. 19 because it had not played enough games this season. But conference officials have said that the Big Ten policy requiring teams to play at least six games to qualify for the title matchup could be adjusted.

Ohio State struggled with the virus toward the end of November and canceled its Nov. 28 game at Illinois. The Buckeyes had earlier missed out on a game when Maryland canceled because of its own virus troubles.

John Pollard, 90, near his home in Brighton on Tuesday.Credit…Jane Stockdale for The New York Times

On Tuesday, a handful of people across Britain — mostly those 80 and over, health care workers and those working in nursing homes — began receiving the newly approved Pfizer vaccine. It was the first day that the inoculations were being administered in any Western nation.

Hilary Nelson, 45, an intensive care unit nurse in Scotland’s Forth Valley Royal Hospital who is also a nurse’s union representative, said it was important to get vaccinated as soon as possible.

“I want to get the vaccine to protect my colleagues, my family, but most of all the patients that we look after,” she said.

She hopes to serve as an example to others in the country, particularly those who may be doubtful of the vaccine’s safety, because she knows the heavy toll the disease has taken.

“I’ve sat with dying patients and had to call their loved ones on the phone,” she said.

“I’ve asked my questions, and I’m satisfied that it is safe.”

John Pollard, 90, was surprised to find out he was among the first patients in Britain to be offered the vaccine.

“Over the years, I’ve had all sorts of vaccinations,” he said. “I’ve never given it any thought really, all I thought was that I would like to not get Covid.” He lives on his own, so his daughter will be bringing him in for the vaccine at a hospital near his home in Brighton.

He plans to spend this Christmas at his daughter’s house, with his family around him and has high hopes for the new year: “If and when I feel if I feel fit enough, I might make a trip to Australia.”

Dr. Matt Morgan, 40, who works in the I.C.U. at University Hospital of Wales, Cardiff, has an appointment booked on Tuesday afternoon. He admitted the first Covid-19 patient to his hospital 38 weeks earlier to the day, and said things have come full circle. He was feeling “proud that science, humanity, the power of globalization, reason and truth” have produced a vaccine, ahead of his appointment Tuesday. “It’s been a very long year.”

His hospital is still dealing with new coronavirus patients on a regular basis, and he described the second wave of infections from this fall as more like a marathon than a sprint.

While he was hopeful about the new vaccine, he worried people may mistake the start of vaccination as the end of the pandemic.

“There’s still certainly going to be people who die between now and spring,” Dr. Morgan said. “There’s still going to be families who spend Christmas alone. So, you know, this won’t in one day make everything OK.”

Dr. Chris Hingston, 45, an I.C.U. consultant at the University Hospital of Wales, was given the Pfizer-BioNTech vaccine in Cardiff, Wales, on Tuesday.Credit…Andrew Testa for The New York Times

At a newly created vaccine center on the outskirts of Cardiff, the capital of Wales, there was a small but steady flow of people coming in on Tuesday morning. Most were health care workers who entered the Cardiff and Vale Therapy Center — a former gymnasium used for rehabilitation therapy — wearing masks.

Betty Spear, a retired pediatric nurse, pulled back the blue curtain from the small cubicle she was working in after having administered the vaccine to a fellow nurse.

“She just cried and said this was such an emotional day,” Ms. Spear said of her most recent patient. “Generally, I think people are extremely happy that the day is coming, that the day has come that they are getting this vaccination.”

She added: “That last lady was very emotional, I think partly because she worked on a Covid ward, so she has seen the consequences and probably the outcomes. I presume she has seen a lot.”

Ms. Spear said she herself was “slightly anxious because it’s a different area but we’ve had a lot of training over the last few days.”

Nearly all of the people vaccinated here were health care workers, and many have experienced the virus’s horrors first hand. They expressed excitement and relief that there was some hope on the horizon for an end to pandemic.

Dr. Chris Hingston, 45, who is an I.C.U. consultant at the University Hospital of Wales, said he initially felt almost guilty for being among the first to receive the shot, pointing to the nurses in Covid wards as among the most in need. But after speaking with colleagues, he decided it was important to be inoculated as soon as possible to provide wider protection for his colleagues and patients.

“From my point of view, well, I’ve no fear of it. But you know, a lot of people out there, I think, are quite worried,” he said. “I don’t feel it’s for myself necessarily, having the vaccine. It’s really for others in many ways.”

When he received his vaccine on Tuesday morning, he likened it to having the flu shot.

“I didn’t even feel it,” he said as he chatted casually with Lynne Cronin, 60, the acting lead nurse at the center who delivered the vaccine.

“You’re exactly the people we need to come through,” she said, after learning that he is an I.C.U. doctor. Ms. Cronin said it had been a huge undertaking to get the site up and running for Tuesday, just days after the vaccine received emergency approval from the British government, but she lauded the local health authorities for their work.

“It’s been a huge ask to get everybody ready to vaccinate,” she said. “We’re still trying to train people up. We needed today and the next few days to sort any teething problems.”

She said other than a few early technical hiccups in the system being used to document the vaccinations, the roll out had been smooth.

“We just need to make sure it’s safe for people, and for my staff to make sure they are comfortable,” she said.

Xavier Becerra served 12 terms in Congress, representing Los Angeles, before becoming the attorney general of California in 2017.Credit…Alex Brandon/Associated Press

President-elect Joseph R. Biden Jr. appeared on Tuesday to formally name members of his health team, and vowed to change the course of the Covid-19 pandemic during his first 100 days in office.

The senior officials Mr. Biden will appoint — including Xavier Becerra, a former congressman who is now the California attorney general, as his nominee for secretary of health and human services — will face the immediate challenge of slowing the spread of the coronavirus, which has already killed more than 283,000 people in the United States and has taken a particularly devastating toll on people of color.

In making his announcement, Mr. Biden asked Americans to wear masks for the first 100 days of his presidency, and pledged to run “the most efficient mass vaccination plan in U.S. history” — including getting 100 million “vaccine shots into the arms of the American people” in his first 100 days. He also said he would set a “national priority” to get children back in school during that time period.

“My first 100 days won’t end the Covid-19 virus — I can’t promise that,” Mr. Biden said. But he added, “I’m absolutely convinced we can change course.”

Mr. Biden’s announcement, in Wilmington, Del., — where he appeared without wearing a boot on the ankle he twisted last month — started around the same time that a “virus summit” hosted by President Trump began at the White House.

In introducing Mr. Becerra, Mr. Biden stumbled a bit, mispronouncing the California attorney general’s last name. Mr. Becerra, 62, a Democrat who had carved out a profile more on the issues of criminal justice, immigration and tax policy, was long thought to be a candidate for attorney general, and he emerged as Mr. Biden’s clear choice for health and human services secretary only over the past few days, according to people familiar with the transition’s deliberations. It was a surprise ending to a politically delicate search that brought complaints from the Congressional Hispanic Caucus about a lack of Latinos in the incoming cabinet.

Other health officials included in the event today:

  • Dr. Rochelle Walensky, the chief of infectious diseases at Massachusetts General Hospital, to lead the Centers for Disease Control and Prevention, replacing Dr. Robert R. Redfield

  • Dr. Vivek Murthy as the surgeon general

  • Dr. Marcella Nunez-Smith to lead the Covid-19 equity task force

  • Jeff Zients as coordinator of the Covid-19 response.

  • Dr. Anthony S. Fauci, whom Mr. Biden has recruited to be his chief medical adviser in addition to continuing in his role as the director of the National Institute of Allergy and Infectious Diseases, is not expected to appear in-person at the event, but he is expected to make a video appearance.

A shopper in Los Angeles, on Monday, where even the mannequins were wearing masks.Credit…Jae C. Hong/Associated Press

The new Covid-19 vaccines from Pfizer and Moderna seem to be remarkably good at preventing serious illness. But it’s unclear how well they will curb the spread of the coronavirus.

That’s because the Pfizer and Moderna trials tracked only how many vaccinated people became sick with Covid-19. That leaves open the possibility that some vaccinated people could get infected without developing symptoms, and could then silently transmit the virus.

If vaccinated people are silent spreaders of the virus, they may keep it circulating in their communities.

“A lot of people are thinking that once they get vaccinated, they’re not going to have to wear masks anymore,” said Michal Tal, an immunologist at Stanford University. “It’s really going to be critical for them to know if they have to keep wearing masks, because they could still be contagious.”

In most respiratory infections, including the new coronavirus, the nose is the main port of entry. The virus rapidly multiplies there, jolting the immune system to produce a type of antibodies that are specific to mucosa, the moist tissue lining the nose, mouth, lungs and stomach. If the same person is exposed to the virus a second time, those antibodies, as well as immune cells that remember the virus, rapidly shut down the virus in the nose before it gets a chance to take hold elsewhere in the body.

The coronavirus vaccines, in contrast, are injected deep into the muscles and are quickly absorbed into the blood, where they stimulate the immune system to produce antibodies.

Some of those antibodies will circulate to the nasal mucosa and stand guard there, but it’s not clear how much of the antibody pool can be mobilized, or how quickly. If the answer is not much, then viruses could bloom in the nose — and be sneezed or breathed out to infect others.

This is why mucosal vaccines are better than intramuscular injections at fending off respiratory viruses, experts said.

The next generation of coronavirus vaccines may elicit immunity in the nose and the rest of the respiratory tract, where it’s most needed. Or people could get an intramuscular injection followed by a mucosal boost that produces protective antibodies in the nose and throat.

A parent says goodbye to their child as kids returned to classes at PS 189 Bilingual Elementary School in the East New York, Brooklyn, on Monday.Credit…Victor J. Blue for The New York Times

As some New York City school buildings reopen this week, Mayor Bill de Blasio has found himself presiding over a starkly unequal school system in which many white families have flocked back to classrooms while most families of color have chosen to learn from home indefinitely.

That gulf is illustrated in a startling statistic: There are nearly 12,000 more white children returning to public school buildings than Black students — even though there are many more Black students than white children in the system overall.

In New York and across the country, politicians and education officials have found that many nonwhite families are not ready to send their children back to classrooms, despite their struggles with remote learning, in part because of the disproportionately harsh impact the virus has had on their communities.

But the fact that so many students of color have chosen remote over in-person learning is raising alarms that existing disparities in the nation’s largest school system will widen, since remote learning has been far less effective.

New York’s issues with remote instruction begin with a lack of basic infrastructure for students learning from home. Many low-income students, including some living in homeless shelters, cannot even log on for classes because they do not have devices or Wi-Fi.

Educators also said they were scrambling to make lessons more engaging for students without much helpful guidance from the city. So while individual teachers and schools have honed creative strategies to improve online instruction, there is no citywide plan to do the same.

Latino students make up the largest share of students returning to classrooms, at about 43 percent, roughly proportional to their overall representation in the school system. But white children, who are less likely to be low-income than many of their peers, make up a quarter of students back in classrooms, even though they represent just 16 percent of overall enrollment.

Black and Asian-American families are significantly underrepresented in reopened classrooms. Just under 18 percent of Black families have chosen to send their children back to school, though those students make up nearly a quarter of the system. Asian-American children, who represent about 18 percent of the overall school system, make up the smallest share of children in classrooms this week, at just under 12 percent.

The card that British people receive when vaccinated records the specifics of the shot and when to get a second dose. Credit…Pool photo by Gareth Fuller

When Britons receive the Pfizer-BioNTech vaccine shots, they also get a wallet-size vaccination card showing that they have received the first of two required doses.

They are not ID cards; they do not contain any personal information, not even the person’s name. Even so, there are worries that they could be the beginning of a “passport” system that would divide society into two tiers, granting cardholders access to some services and businesses, like boarding a plane or eating at a restaurant, while others are excluded.

British health officials have argued that the cards are merely meant as a reminder of when a patient received the first shot and when they are scheduled to get the second, three weeks later.

The blue-and-white vaccination card, seen in images released by health officials, has spaces to record the vaccine name, dates of the injections and batch numbers. “Don’t forget your Covid-19 vaccination,” it reads. “Make sure you keep this record card in your purse or wallet.”

Britain faces tremendous logistical and security challenges to vaccinate millions of its citizens, and other countries will face them as well when they begin vaccination programs. The authorities have highlighted the need for a reliable record of who has been vaccinated, and have discussed the idea of issuing people documents certifying that they have received the vaccine or recovered from the disease, and thus presumably have some immunity.

But ministers in Prime Minister Boris Johnson’s government have brushed off the idea that the vaccination card will become a so-called immunity passport, and it remains unclear whether such a system will ever exist in Britain. Scientists are skeptical about the idea as well.

Two experts at the University of Birmingham noted in an article published on The Conversation that data on protected people following vaccination had not yet been published. “This is important because if we don’t understand the key ingredients for protection, we can’t monitor immunity effectively,” the experts — KK Cheng, a professor of public health and primary care, and Zania Stamataki, a lecturer in viral immunology, wrote on Monday.

They argued that while the vaccine greatly reduces the chance that the recipient will become severely ill, vaccinated people could still transmit infection to others, limiting an immunity passport’s usefulness.

“Being personally protected following successful vaccination does not absolve us of social responsibility,” they said.